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Abstract 
 
 
 The stated mission of the Board of Pharmaceutical Specialties (BPS) with regard 
to specialization is, via board certification, to recognize specialty areas, define skill 
standards for those specialty areas, and evaluate the knowledge and skills of individual 
Pharmacy specialists.  The perceived or real benefits to the pharmacist of pursuing board 
certification are unknown.  These benefits can be evaluated by separating into values 
(valences) and instrumentalities, the latter of which is the perceived or known probability 
that a performance will lead to an outcome.  The primary purpose of this study was to 
determine the differences in values and instrumentalities perceived by the pharmacist, 
and differing calculated forces of motivation, using an Expectancy Valence equation, 
between board certified pharmacists and those who were not. 
 A survey instrument, the Advanced Certification Index for Pharmacists (ACI-P), 
was designed to test instrumentalities, values, and calculated force of motivation.  The 
ACI-P was deployed via electronic mail and the internet in cooperation with four major 
Pharmacy organizations and the Board of Pharmaceutical Specialties.  Four direct 
comparisons between the two groups were completed. These were instrumentality, 
valence, valence-minus-instrumentality and valence-times-instrumentality.  Additionally, 
the components of the valence and instrumentality products (the VI Scores) were 
multiplied by expectancy (anticipated chance of success of an effort leading to successful 
performance) resulting in a force of motivation calculation for each pharmacist’s score.   
  The ACI-P was deployed in the summer of 2007.  Of the 2,274 pharmacists who 
began the survey, 2,129 completed all of the survey question sets for a completion  
vi 
 
percentage of 93.7%.  A total of 2,057 of 2,129 completed surveys were retained for the 
research data representing a clean data rate of 96.6% of those completing all questions 
and 90.5% of those initiating the survey.  This data set was comprised of 496 (24.1%) 
non-board certified pharmacists and 1,561 (75.9%) board certified pharmacists. 
 Validation and reliability of the ACI-P was confirmed via parallel axis analysis 
and Cronbach’s alpha reliability coefficient.  There were two factors or domains found in 
the data and these were Professional, Career and Personal (PCP) and Financial Support 
(FS).  Cronbach’s alpha for the PCP factor or domain was 0.94 and the FS domain had an 
alpha of 0.81.  The constructs were validated and the items addressed within the 
constructs of PCP and FS were reliable.  The overall Cronbach’s alpha reliability 
coefficient for the ACI-P was 0.94.   
 In the four major comparisons, there were significant differences between non-
board certified and board certified pharmacists.   
 The primary value used for the motivational force calculation was based on 
valence-times-instrumentality-times-expectancy.  The valence-times-instrumentality 
value was the VI score or VIS.  The summed VI scores for the non-board certified 
pharmacists were in general lower (303.54; SD 101) than those for the board certified 
pharmacists (343.82; SD 83), and these were statistically different (t= -8.03, p<.0001).   
 The overall expectancy mean for non-board certified pharmacists was 4.05 and 
4.4 for board certified pharmacists (5-point Likert scale), and these were significantly 
different (t = -9.16, p<.0001). 
 The overall motivational force calculated using the ACI-P scoring methodology 
yielded a force of motivation to seek board certification of 1249 (95% CI 1201-1296) for 
vii 
 
non-board certified pharmacists and 1521 (95% CI 1499-1544) for board certified 
pharmacists. The differences were statistically significant. (t=10.15, p=<0.001).  A 
tipping point in the range of 1500-1520 was identified that would indicate a 95% 
probability that a pharmacist scoring in this range would be a board certified pharmacist. 
 The results of this study show that there were significant differences in 
motivational factors between non-board certified pharmacists and those that were board 
certified with the latter scoring higher on nearly every measure.  The ACI-P survey 
instrument was shown to be a valid and reliable tool for evaluation of the force of 
motivation for pharmacists to seek board certification. 
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Chapter 1. Introduction 
 
Background 
 Drug therapy is an integral component of the modern health care delivery 
system accounting for 10% of health care spending and 16% of incremental 
spending.
1
  Market introduction of drugs and the rate of drug approval has doubled in 
the last three decades while expenditures for research and development have 
increased more than twelve times.
2
  These new drugs and new drug delivery systems 
offer options for the treatment of conditions that were deemed untreatable just a few 
years ago.  In addition to an increasing number of drugs, the types of drugs have 
increased in complexity.  Currently there are more than 400 biotechnology medicines 
in the drug pipeline.  “These include 210 medicines for cancer, 50 for infectious 
disease, 44 for autoimmune diseases and 22 for AID/HIV and related conditions”.
3
  
Newer genetically engineered and biotechnology drugs have set the stage for a 
paradigm shift in healthcare, particularly in the practice of Pharmacy.  New practice 
models and practitioner competencies are required to assure that the needs of the 
public and health care system are met.  Specialization in healthcare has become more 
of a need as these rapid advancements in drug therapy and technology have created an 
environment requiring extensive knowledge of the many facets of healthcare and how 
drug therapy can best be incorporated to provide optimal patient care.
2, 4-6
  
Specialization is an evolution within a profession to accommodate new knowledge, 
techniques and/or technology into the improvement of health care.  “Specialization in 
the healing arts is unique because it places the needs of the person receiving care at 
 2 
the center of concern.” 
5, 7
  Accommodating these changes calls for specialization and 
specialized practitioners in Pharmacy.  Does a pharmacist stand to gain from 
achieving specialization?  Why do qualified pharmacists seek specialty board 
certification?  Why do qualified pharmacists not seek board certification?  Is 
specialization attainable without formal recognition of an “approval body”?  The 
purpose of this research was to examine and compare pharmacist groups seeking or 
not seeking board certification.  
 
Board Certification in Pharmacy 
 Becoming board certified in Pharmacy is a rigorous and involved process.
8, 9
  
It is also voluntary and may not lead to a tangible reward.  In the practice of 
Medicine, and in some other health care disciplines, board certification may not be 
required but is highly desired for practice.  It is required for advanced practice 
licensure in most states for nursing.  Reimbursement and/or accreditation processes 
may also be tied to the number of board certified practitioners, especially physicians, 
in a practice or area.
9
     Although not required, there are a number of factors which 
motivate pharmacists to pursue board certification, as well as a perceived value of 
those motivating factors.  It is reasonable to expect that the number of pharmacists 
seeking board certification is related to these factors and their perceived values.   
Studies assessing expectations and related perceived values of a pharmacist pursuing 
board certification were not found in the literature.    
 
 3 
Description of the Problem 
 There are potential benefits to employers, and other health care providers, of 
pharmacist specialization.  It has also been postulated, and is indeed the point of 
board certification, that such pursuit and accomplishment produces a better provider 
of care.  However, in the medical profession, this has yet to be definitively proven.
9
   
 The practice setting may affect the perceived or actual benefits to a 
pharmacist.  In areas where financial reward is greater, that particular benefit may 
take prominence.  In practice areas that have a preference for specialty certification, 
work related benefits may move to the forefront.   
 Board Certification in any Pharmacy practice area has specifics that make it 
unique, hence the specialization designation.  Contributing factors may be a perceived 
difference due to the fact that the pharmacist’s practice area is quite different from 
standard clinical practice and they seek some level of differentiation.  There may also 
be more reward or benefit within a particular specialty than the others.  The 
tangibility of these rewards may be questionable as there are a number of former 
board certified pharmacists that have elected to not maintain their certification.  To 
evaluate the issues of possible benefits or rewards specific to being a board certified 
pharmacist, a conceptual model and survey instrument based on Expectancy theory 
was developed.   Principal to this model and instrument design were the values 
(valence), probability of performance leading to the outcome (instrumentality) and 
the attributed expectation (expectancy).   
 Four domains of valence and instrumentality were proposed.  They were: 
1. Personal 
 4 
2. Financial 
3. Career 
4. Professional 
 The purpose of the use of this theory was to fashion a survey instrument based 
on its components and not to prove the validity of the theory or its application to this 
research.   Some discussion focuses on potential uses and applications of the 
instrument derived from this study. 
 
Survey Instrument Conceptual Framework 
 Valence-instrumentality-expectancy (VIE) theory is a major theory of 
motivation and work behavior.  It may also be called Expectancy theory, Expectancy-
Valence (EV), instrumentality theory, and path-goal theory.  The three major 
variables are expectancy, instrumentality and valence (value).
10-12
  For the purpose of 
this study, VIE is an explanatory acronym that is used as a synonym for Expectancy 
theory and these two terms or names may be considered interchangeable.  It is a 
process theory in that it seeks to identify the relationship between the variables in a 
dynamic state as they affect individual behavior.  Vroom, the initiator and synthesizer 
of Expectancy/VIE theory, postulated that one’s perception of a link between effort 
and reward, plus values attributed to aspects of the task or rewards at hand, lead to 
motivation at work. In this theory, the relationships between the inputs are more the 
focal point than the inputs themselves.
12
 
 Figure 1-1 is a graphical depiction of Expectancy theory listed as the 
components of VIE Theory. 
10
  In this figure, expectancy is a perceived probability  
 5 
Effort    0.5   Performance    Rewards  
              0.9  
              0.5 Pay Raise  6 
 Promotion  8 
                0.3  
 Longer holiday 5 
            0.6 
 Company car 9 
 
 Expectancy    Instrumentalities      Valences 
 
Figure 1-1. Expectancy Theoretical Model Demonstrated as a Model of Motivation  
(Reproduced with Permission of the Pharmaceutical Journal)
10
  
 
 6 
that an effort will lead to a successful performance.  In this example the individual in 
question believes that there is a 50% chance that a particular effort will lead to a 
successful performance therefore the expectancy is listed as the decimal equivalent or 
0.5.   
 Instrumentalities, also called “cognized instrumentalities” are perceived 
probabilities that performance will lead to a particular reward.  These also are 
presented as the decimal equivalent of the probability so 90% performance-to-reward 
expectation (instrumentality) is presented as 0.9.  In this example, 90% perceived 
probability that a particular performance will lead to a pay raise is 0.9.  Valences are 
the level of value to the individual.  Valences are independent of 1) Effort to 
Performance (E ? P) and 2) Performance to reward (referred to in VIE theory as 
Outcomes) expectancies (P ? O).  These are generally listed on a 5 or 10 point scale 
in whole numbers since they are values not probabilities.  (Reproduced with 
permission of the Pharmaceutical Journal).
10
  These mathematical associations are 
covered in more detail in Chapter 2. 
 A conceptual framework examining the design considerations for the survey 
instrument is listed in Fig. 1-2.   The conceptual framework presented demonstrates 
one way of relating these different potential areas of influence.  The purpose of this  
research was not to validate these suggested domains but to evaluate the components 
that fall within each as designed within the survey instrument.   There were questions 
framed and designed to fit within the four domains of career, professional, personal 
and financial.    
    
 7 
 
 
Figure 1-2.   Conceptual Framework of Practitioner Valence, Instrumentality and  
 Expectancy Perceptions of Board Certification (Original work adapted  
 from theoretical VIE Model of Motivation) 
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Research Questions 
 The principal question asked in this research was; what are the differences in 
instrumentalities, values placed on those outcomes and force of motivation between 
board certified pharmacists and those that are not board certified?  Instrumentalities 
are perceived probabilities that performance will lead to particular benefits, rewards 
or outcomes. 
 The following specific questions, based on the perception of the pharmacist, 
were addressed: 
1. What were the differences in instrumentalities (probabilities) between 
board certified and non-board certified pharmacists?  
2. What were the differences in valences (values) between board certified 
and non-board certified pharmacists? 
3. What were the differences in the product of instrumentalities and valences 
between board certified and non-board certified pharmacists? 
4. What were the differences between the value-minus-instrumentality 
calculation between board certified and non-board certified pharmacists?  
5. What were the differences in calculated force of motivation, as defined by 
the Expectancy Value (VIE) model, between board certified and non-
board certified pharmacists? 
6. Was there a tipping point where a certain combination of factors would 
indicate a pharmacist would be board certified, i.e. would a certain 
calculated overall force of motivation be definitely different in board 
certified pharmacists than in those that were not board certified?  
 9 
7. Were there certain instrumentalities, valences or combinations of 
instrumentalities and valences, as well as expectations, as defined by the 
Expectancy Value (VIE) model, that were the most valued by pharmacists 
that are board certified? 
 
Purpose of the Study 
 The primary purpose of this study was to compare the values, 
instrumentalities, expectations, and calculated force of motivation between 
pharmacists that choose to seek or not seek board certification in a Pharmacy 
specialty.  
 
Objectives 
 The objectives of this study were to: 
1. Create a survey instrument and utilize to determine the differences in 
motivating factors (forces) between board certified and non-board certified 
pharmacists. 
2. Determine the overall scores of those factors or forces. 
3. Evaluate the relationships among and between the factors or forces. 
4. Compare motivating factors between board certified pharmacists and those 
that were not board certified in specialty Pharmacy practice. 
5. Compare calculated motivational force between board certified 
pharmacists and those that were not board certified in specialty Pharmacy 
practice. 
 10 
Definitions of Terms and Concepts 
• Expectancy: Expectancy refers to the expectation, or anticipated chance of 
success of an effort leading to successful performance.  In this case that would 
be exertion of effort leading to achievement of the designation of board 
certification in a specialty by BPS.
10-12
  
• Valence: Valence refers to the perceived value that correlates to the 
instrumentality of the particular outcome.  This may also be interpreted as 
value to the individual.
10-12
   
• Instrumentality: Instrumentality is a perceived or known probability that a 
performance will lead to an outcome.  It is also called a performance-to-
outcome expectancy (P ? O). This may also be called cognized 
instrumentality.
10-12
  
• VIE (Valence-Instrumentality-Expectancy) Theory: VIE, also called 
expectancy theory, it is a major theory of motivation and work behavior.  It is 
a process theory in that it seeks to identify the relationship between the 
variables in a dynamic state as they affect individual behavior.  Other 
synonyms include instrumentality theory and path-goal theory.
10-12
 
• Expectancy Theory: Also called VIE theory, it is a major theory of 
motivation and work behavior.  It is a process theory in that it seeks to identify 
the relationship between the variables in a dynamic state as they affect 
individual behavior.  Other synonyms are instrumentality theory and path-goal 
theory.
10-12
 
 11 
• Demographic Variances and Inputs: Pharmacists may be influenced by 
demographic inputs and these may be categorized.  Some of these 
characteristic demographic categories may or may not have a bearing on the 
outcome of the study.  Categories of characteristics, or demographic variances 
(inputs), captured during the survey process in this study were: 
1. Current professional Pharmacy organizations memberships 
2. Age 
3. Gender 
4. Current board certification status 
5. City of primary practice setting 
6. State, territory or location of primary practice setting 
7. Practice position/title/role at primary practice site (could be multiple) 
8. Type of practice setting 
9. Average number of hours worked per week in the practice of Pharmacy 
10. Entry level Pharmacy degree 
11. Highest level Pharmacy related degree 
12. Type of Pharm.D. Degree (if earned) 
13. Residency completion status and type 
14. Number of years worked in full or part-time status as a licensed 
pharmacist 
15. Number of years worked in current specialty or practice focus 
16. Primary reason for seeking board certification 
17. Secondary reason for seeking board certification 
 12 
• Organizational Inputs: This refers to the various groups and associations 
that may be considered influential in the pharmacist’s decision to become a 
board certified pharmacist.  For the purposes of this study, those considered 
were as follows: 
1. Board of Pharmaceutical Specialties (BPS) 
2. Professional organizations were the American Society of Health-System 
Pharmacists (ASHP), American Pharmacists Association (APhA), 
American College of Clinical Pharmacy (ACCP), American Association 
of Colleges of Pharmacy (AACP) 
3. Company (employer) 
• AMA: The American Medical Association is the nation’s largest physician’s 
professional association and by their own credo advocate on the part of the 
nation’s health.
13
  
• ABMS: “The American Board of Medical Specialties (ABMS), a not-for-
profit organization comprising 24 medical specialty boards, is the pre-eminent 
entity overseeing physician certification in the United States.”
14
  
• AMA Council on Medical Education: Also known as the American Medical 
Association Council on Medical Education.  “The Council on Medical 
Education (CME) formulates policy on medical education by recommending 
educational policies to the American Medical Association (AMA) House of 
Delegates, through the AMA Board of Trustees. The Council is also 
responsible for recommending the appointment of representatives to 
accrediting bodies and to other national organizations.”
13
  
 13 
• Board of Pharmaceutical Specialties (BPS): The Board of Pharmaceutical 
Specialties (BPS) was established by the American Pharmaceutical 
Association (now the American Pharmacists Association, APhA) in 1976.  
The stated mission of BPS with regard to specialization is, via board 
certification, to recognize specialty areas, define skill standards for those 
specialty areas, and to evaluate the knowledge and skills of individual 
Pharmacy specialists.  The purpose of board certification was to respond to 
the rapidly evolving requirements of patients and other health care 
professionals for pharmacists.
4, 15-17
  
• Pharmaceutical Care: Pharmaceutical care is a manner of Pharmacy practice 
that strives to promote health, prevent disease, and assess, monitor, and 
modify medication use to assure that drug therapy regimens are appropriate, 
safe and effective.
18
 
• APhA: “The American Pharmacists Association (APhA), a national 
professional association of pharmacists, founded in 1852 as the American 
Pharmaceutical Association, is the first-established and largest professional 
association of pharmacists in the United States.”
19
 
• ASHP: ASHP is the American Society of Health-System Pharmacists.  It was 
known as the American Society of Hospital Pharmacists until the scope and 
name change in 1995.  It is a “national professional association that represents 
pharmacists who practice in hospitals, health maintenance organizations, long-
term care facilities, home care, and other components of the health care 
system.”
20
   
 14 
• ACCP: “The American College of Clinical Pharmacy (ACCP) is a 
professional and scientific society that provides leadership, education, 
advocacy, and resources enabling clinical pharmacists to achieve excellence in 
practice and research.  ACCP’s membership is composed of practitioners, 
scientists, educators, administrators, students, fellows, and others committed 
to excellence in clinical Pharmacy and patient pharmacotherapy.”
21
 
• AACP: “Founded in 1900, the American Association of Colleges of 
Pharmacy (AACP) is the national organization representing the interests of 
Pharmacy education and educators. [It is comprised of] all 105 U.S. colleges 
and schools of Pharmacy including more than 4,300 faculty, 48,500 students 
enrolled in professional programs and 3,600 individuals pursuing graduate 
study. AACP is committed to excellence in Pharmacy education.”
22
 
• Clinical Pharmacy: “Clinical Pharmacy is a health science discipline in 
which pharmacists provide patient care that optimizes medication therapy and 
promotes health, wellness, and disease prevention. The practice of clinical 
Pharmacy embraces the philosophy of pharmaceutical care; it blends a caring 
orientation with specialized therapeutic knowledge, experience, and judgment 
for the purpose of ensuring optimal patient outcomes. As a discipline, clinical 
Pharmacy also has an obligation to contribute to the generation of new 
knowledge that advances health and quality of life.”
21
 
•  Accreditation Council for Pharmacy Education (ACPE): “Accreditation 
Council for Pharmacy Education (ACPE) is the national agency for the 
accreditation of professional degree programs in Pharmacy and providers of 
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continuing Pharmacy education. ACPE was established in 1932 for the 
accreditation of Pharmacy education, and in 1975 its scope of activity was 
broadened to include accreditation of providers of continuing Pharmacy 
education.   The Council is an autonomous and independent agency whose 10 
member Board of Directors is comprised of representatives of  the American 
Association of Colleges of Pharmacy (AACP), the American Pharmacists 
Association (APhA), the National Association of Boards of Pharmacy 
(NABP) (three appointments each), and the American Council on Education 
(ACE) (one appointment).”
23
 
• SAS: SAS is an acronym for statistical analytical software.  This research 
employed SAS Version 9.1 TS Level M3, Copyright © 2002-2003 by SAS 
Institute Inc., Cary, NC, USA.  All Rights Reserved. 
24
 
 
 
Relevance to Pharmacy, Health Outcomes and Policy Research 
 Board certification in many health specialties is preferred or expected and, in 
some cases, driven by financial reimbursement or rights to practice in certain settings.  
In Pharmacy, however, becoming board certified in specialty areas is still a voluntary 
effort.  This is true in all specialty areas of Pharmacy practice.
8, 9
  Therefore, 
determining the motivational factors and values ascribed to those factors is essential 
for determining measures that could be taken to increase the numbers of pharmacists 
seeking certification.  The scope of Pharmacy is expanding.  Board certification could 
become more important as pharmacists take on new challenges.  Indeed, the interest 
of pharmacists in seeking board certification could be instrumental in acceptance of 
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new practice models for pharmacists, as well as helping to form a structure for 
reimbursement of cognitive clinical activities.
16, 17, 25
  
 This research was expected to offer information on differences in factors or 
influences between board certified and non-board certified pharmacists.  This 
information has the opportunity of determining a level of motivation that may be able 
to predict whether a pharmacist might pursue board certification.  This could have an 
impact on the overall pursuit of board certification by pharmacists.  An effective tool 
that could identify those individuals would be of enormous value.  This information 
may add to the knowledge needed for continued review and possible modification of 
the certification process.  If value to a pharmacist is not present or perceived then a 
road map of where value needs to be improved would be helpful. 
 
Assumptions 
1. Pharmacists involved in completing the study’s survey would respond to 
survey items as honestly and accurately as possible. 
2. Pharmacists taking the survey would only complete one survey. 
3. Sufficient numbers of pharmacists would have internet access to assure an 
adequate number of respondents. 
4. Pharmacists that respond to the internet based survey would represent the 
targeted pharmacist population. 
5. There is sufficient evidence of the effectiveness and value of the 
pharmacist clinician. 
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Limitations 
 The following limitations were identified prior to initiation of research: 
1. The study references surveys completed by the Board of Pharmaceutical 
Specialties and others utilized and referenced by BPS in 1989, 1996, 2002 
and 2004.
26
  There are economic, socioeconomic, and health care system 
factors that may have changed in the years between surveys that were not 
measured in the surveys. 
2. Limited data are available on the number of pharmacists licensed to 
practice in the United States, as well as overlap of practice areas, e.g. 
pharmacotherapy and nutritional support. 
3. Although BPS records the number of pharmacists who seek board 
certification, limited data are available on the percentage of licensed 
pharmacists seeking board certification in a specialty area because practice 
area focus and total numbers of pharmacists in practice are difficult to 
obtain and confirm. 
4. Prior studies assessing values associated with expectations, 
instrumentalities, and values related to Pharmacy specialization were not 
found in the literature. 
5. The time and expenses involved in pursuing board certification vary 
among candidates and this variance could have biased the results. 
6. Poor survey return rate could have impaired interpretation of the results. 
7. Duplicate entries into the survey instrument could not be prevented. 
8. Non-pharmacist entries into the survey instrument could not be prevented. 
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Organization of the Dissertation 
The remainder of this dissertation is organized into the following four 
chapters.  Chapter 2 reviews the literature relative to the history and process of 
becoming board certified in a Pharmacy specialty.  The literature related to 
motivational theories and expectancy theory is also reviewed as it pertains to the 
reason for the selection of the expectancy theory mathematical model for the survey 
instrument design.  
Chapter 3 provides a description of the methods used, including the research 
design, inclusion and exclusion criteria, data collection, and statistical methodology.  
Chapter 4 describes the results and findings of the research and offers some 
discussion regarding the mathematical aspects of expectancy theory.  This is followed 
in Chapter 5 by a review of the study conclusions and discussion. 
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Chapter 2. Literature Review 
 
History of Pharmacy Specialization 
 The practice of Medicine has long utilized specialization to differentiate 
practitioners.  For over 100 years the medical profession has formally recognized 
specialty practice.  As far back as the recognition of a priest, shaman, or medicine 
man as having special knowledge, insight, or power to heal, specialization in the 
healing arts has been in place.  That difference set them apart from the rest of the 
village, community, clan, or town.
9, 27
   Medicine, nursing, optometry, and dentistry 
exhibit a history of advanced level credentialing.
9, 28
   The history of specialization in 
Medicine began in the 1920’s and 1930’s and was a result of the developments in 
medical science and was perhaps causal in the resulting improvements in the delivery 
of medical care. Specifically, specialization in the United States in Medicine can be 
seen as a result of the need to master all the special tools and skills needed for the 
delivery of appropriate and targeted health care.  In addition to the development of 
these skills, social, political and economic forces shaped the framework of the 
medical specialties.  In the practice of Medicine, specialty areas developed around 
organ systems or functions.  The current specialty titles are clear indicators of these.  
Some examples of medical specialties are cardiology, obstetrics, gynecology, 
dermatology, thoracic surgery, ophthalmology, otolaryngology, gastroenterology, and 
neurosurgery.  Clearly, the area or particular anatomical need or function played a 
significant part in medical practice’s path toward specialization.  Early on, individual 
physicians were the only persons to assess their specialization qualifications.  Lacking 
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was a formal process and a set of guidelines, requirements and rules to determine who 
was indeed qualified to be known and practice as a specialist.  Medical educational 
institutions and specialty societies collaborated to create boards to define specialty 
qualifications.  These boards would function both to identify requirements of a 
specialist and to assure the public of the specialist’s qualifications.
9, 28
   
 The first specialty board formed in the United States was the American Board 
of Ophthalmology established in 1917.  Candidates wishing to practice 
ophthalmology had established guidelines for their education, training, and 
importantly, evaluation of their skills.  The American Board of Otolaryngology 
followed in 1924.  In 1930 the American Board of Obstetrics and Gynecology was 
formed.  They were joined shortly with the formation of the American Board of 
Dermatology and Syphilology in 1932.  Several other specialty groups followed with 
the formation of the American Board of Internal Medicine in 1936 and the American 
Board of Surgery in 1937.
9, 28, 29
   
 Board certification for physicians was based on the concept that physician 
specialists who met certain qualifications and standards, and having attained the 
necessary level of knowledge, skill, and experience in their respective area of practice 
offered a higher level of care than practitioners who did not.  While it may seem 
intuitively logical that such specialists would produce better health care outcomes, 
with lower morbidity and greater efficiency, this has not been validated by any 
studies.
9
  Some have argued that the highly skilled and trained specialist dominated 
care model actually does not improve outcomes over simpler and less expensive   
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models of health care.
30
  However, this has not deterred or altered the progression and 
acceptance of the model of board certification as a means to improve healthcare. 
Since 1934 specialty boards in Medicine have been officially recognized by 
the American Board of Medical Specialties (ABMS) and the American Medical 
Association (AMA) Council on Medical Education (CME).  The American Board of 
Medical Specialties approves 24 medical specialties and has become the standard by 
which the profession and the public recognize physician specialists in the United 
States.  Additionally, 180 other non-ABMS boards issue specialty certifications.
9, 29
   
Board certification is not currently required for a physician to practice 
Medicine in most areas.  But there is value to a specialty certification.  Managed care 
organizations require a certain percentage of the members of a medical staff to be 
board certified for many contractual arrangements and the Joint Commission on 
Accreditation of Health Care Systems (JCAHO) and the National Committee of 
Quality Assurance (NCQA) incorporate medical specialty board certification in their 
accreditation standards.  These measures of acceptance provide a basis for the public 
view of medical specialty board certification as a measure of expertise and 
achievement and seem to be the entrenched pattern of acceptance.
9, 31
   
 
Specialty Recognition and Credentialing in Pharmacy 
 Throughout most of its history Pharmacy has remained undifferentiated.    
Hospital Pharmacy first began movement toward differentiation in the late 1960’s and 
through the mid-1970’s.  This environment of thought began to require a new model 
of practice.  Pharmacists practicing in these areas took on new roles.  Activities and  
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communications in the late 1960’s and through the mid 1970’s addressed this new 
practice model and the need for the development of a “new practitioner” who had 
unique roles distinctive from those of the traditional dispensing pharmacist.
9, 32
    
 Early pioneering pharmacists participated with physicians in a variety of tasks 
including therapeutic decision making.  These tasks offered new opportunities.
9
  
Recommendations were made to organize hospital Pharmacy departments in novel 
ways to recognize and utilize what were then the new Pharmacy specialists.  It was 
suggested that the medical model of specialization be applied to Pharmacy.
9, 32
   
Between the years 1973 and 1976 many activities, resulting from the movements 
dating back to the late 1960’s and through the early 1970’s, took place that moved the 
profession of Pharmacy into the realm of specialization.
4, 6, 17, 33
  There are a variety of 
ways that pharmacists may be additionally trained and credentialed to meet the needs 
of their expanding and more specialized roles.  These include residencies, 
fellowships, certificates and board certification.
4, 6, 9, 15-17, 34
   
 The American Pharmaceutical Association (now the American Pharmacists 
Association, APhA) established the Board of Pharmaceutical Specialties (BPS) in 
1976.
5
  The stated mission of BPS with regard to specialization is, via board 
certification, to recognize specialty areas, define skill standards for those specialty 
areas, and to evaluate the knowledge and skills of individual Pharmacy specialists.  
The purpose of board certification was to respond to the rapidly evolving 
requirements of patients and other health care professionals for pharmacists.  The first 
Pharmacy specialty recognized by BPS was Nuclear Pharmacy, which occurred in 
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1978.  The others were Nutrition Support Pharmacy (1988), Pharmacotherapy (1988), 
Psychiatric Pharmacy (1992), and Oncology Pharmacy (1996).
4-6, 8, 9, 15, 17
   
  Since the inception of Pharmacy board certification in these areas, research 
and emphasis has been focused on the value that this specialization brings to the 
patient, other members of the health care team and the health care system as a whole.   
Areas of research have been in demonstrating higher levels of practice, better patient 
outcomes, and cost reduction, where possible.  Studies evaluating the effectiveness of 
the pharmacist in pharmaceutical care have demonstrated successful activities in 
lower drug costs and reduced overall health care expenditures, lower mortality rates 
and prevention of errors.  Meta-analyses and individual articles have outlined 
pharmaceutical outcomes research as well as scientific applications of pharmaceutical 
care.  These reveal that indeed pharmacists do make an impact.
35-56
  
  Pharmaceutical care is designed to promote health, prevent disease, and 
assess, monitor, and modify medication use to assure that drug regimens are safe and 
effective.
25, 34-43, 48, 51
 In general, it appears that pharmacists’ activities in the hospital, 
nursing home, retail/ambulatory practice and clinic settings have been well received 
and have demonstrated the effectiveness of pharmaceutical care.  For the purposes of 
this study, it will be assumed that at this point in the development of the model of 
pharmaceutical care that there is sufficient research evidence of the effectiveness and 
value of the pharmacist clinician.
35-56
  These findings, along with the development of 
increased and improved automated systems, and the move to the entry-level Doctor of 
Pharmacy (Pharm.D.) degree, have prompted some medical organizations and 
governmental bodies to strongly support the expanded role of pharmacists.
25
  Official 
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recognition via increased pay, and/or ability to receive reimbursement for services, 
has been offered by others.
25, 57, 58
  
 Becoming board certified in Pharmacy is a rigorous and involved process.
8
  It 
is also voluntary and perhaps lacks a tangible reward.  In the practice of Medicine, 
and in some other health care disciplines like nursing, board certification may not be 
required but is highly desired for practice.  Reimbursement and/or accreditation 
processes may also be tied to the number of board certified practitioners, especially 
physicians, in a practice or area.  Although not required, there are a number of 
factors, as well as a perceived value of those motivating influences or factors, which 
may motivate pharmacists to pursue board certification.  It is reasonable to expect that 
the number of pharmacists seeking board certification is related to these factors and 
their perceived values.   Studies assessing associated expectations and values of 
pharmacists pursuing board certification were not found in the literature.   
 Although some professional groups and societies have suggested board 
certification by pharmacists as a necessary credential for acceptance as a peer 
practitioner,
25
 the number of pharmacists seeking board certification in the various 
specialties is relatively small.  From 1995 to 2006 the numbers of board-certified 
Pharmacy specialists has grown from 1649 to 4940, a three-fold increase.
59
   
 This type of percentage increase would seem to be impactful.  But during this 
same period it was estimated that fewer than 5% of practicing pharmacists had sought 
any advanced practice certification.
9, 33
 Of the currently licensed pharmacists, precise 
percentages of those seeking certification is difficult to determine due to the lack of 
records of numbers of all practitioners and/or possible overlapping practice areas, e.g. 
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pharmacotherapy and nutrition support.  As in any health care discipline, becoming 
board-certified represents an additional amount of effort on the part of the candidate 
beyond licensure.    
 The requirements for becoming certified in a Pharmacy specialty area are 
multi-faceted.  Typically it requires many hours of training and experience (which 
might be gained in several ways including supervised work experience, postgraduate 
academic programs, certificate training programs, residency, etc.) and successful 
completion of a rigorous written exam.
8, 9, 60
  Once a pharmacist has obtained 
certification, recertification by written exam is required every seven years.
8, 60
   One 
question this study sought to answer was what would motivate a pharmacist to exert 
the time, energy, and money to obtain this certification, given the fact that it was not 
required for him or her to obtain or maintain employment?   
 In the case of the physician or the nurse-practitioner, the motivating factors 
are more obvious.   They may seek certification as a condition of practice, and they 
can therefore expect to practice under the umbrella of their sanctioning organization.  
They can also expect to reap the benefits, e.g. enhanced professional stature or 
abilities to provide services for certain health insurance or third-party payment 
providers that require such certification, such a level of achievement affords.  
However, they are also proceeding with the knowledge of what they would not be 
able to do without that certification.  This latter limitation may be imposed by the 
sites where they practice or by regulations in their area of practice.  
 Since board-certification in Pharmacy is not currently required, the pharmacist 
must recognize or perceive that there are benefits of board certification. One survey in 
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1996 of 733 BPS certified specialists sought to measure the tangible and intangible 
benefits that BPS certification might bring to the pharmacist.   Of the respondents, 
90% practiced Pharmacy within their specialty.  Cited as their reason for pursuing 
board certification were 1) to test their competence (65.5%); 2) increase marketability 
(49.6%); and 3) to increase their acceptance by other health care professionals 
(34.3%).
61
  A small number noted financial or career boosts that resulted from the 
certification.   A prior survey in 1989 of board certified pharmacists found 72% of 
respondents listed self-recognition and acceptance as their principal satisfactions.
61
  
This same group reported the least satisfaction related to employers.  It is not 
immediately obvious as to whether their employers attached any value to their status 
because respondents were able to answer with multiple responses.  Other studies have 
found that some financial reward, e.g. slightly higher compensation, may exist for 
certain specialists like those certified in pharmacotherapy.  BPS surveyed 1141 board-
certified pharmacists in 2002.  Less than 5% reported that certification was required 
for their job, although 31% listed it as preferred by their employers.  This study found 
that there was some employer recognition.  However, only reports of public 
recognition (21%), financial reimbursement for certification (33%), and financial 
reimbursement for recertification (24%) managed to exceed the 20% mark.
61
   
 In the 2004 on-line survey of BPS-Certified Specialists, represented in Table 
2-1, some changes were noted. Specifically 31% of total respondents reported no 
formal employer recognition which could mean that 69% did. This demonstrates a 
slight decrease from 2002 where 333 out of 1135 respondents (29%) reported no 
recognition, so 71% were apparently recognized in some way.  Other attestations of  
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Table 2-1.   Tangible and Intangible Benefits that BPS Certification May Bring to 
the Pharmacist as Reported in BPS Online Survey Results 2004
63, 64
  
Survey Item 
Number of BPS responses 
(Multiple Allowed) 
Percentage of BPS 
Respondents (N=1995) 
Pay Certification Costs 686 34% 
No Recognition 618 31% 
Pay Recertification Costs 433 22% 
Public Notice 325 16% 
Hiring Priority 324 16% 
Salary Increase 302 15% 
Pay BPS Annual Fee 296 15% 
Increased Responsibility 224 11% 
Promotion Priority 137 7% 
One-time Pay Bonus 98 5% 
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their accomplishments were spread among a variety of types of recognition and 
respondents could answer with multiple responses.  It should be noted that in the 
surveys done in 1996, 2002, and 2004,  respondents could choose as many 
recognition types (responses) as they wanted, therefore the number of recognition 
responses greatly exceeded the number of survey respondents.
62
 
 In this survey, 34% reported that their employer paid their certification costs 
and 22% had their employer pay their recertification costs. Tangible or intangible 
rewards for either hiring priority or public notice were tied at 16%. And 15% reported 
a salary increase which was the same as those saying their employer paid their annual 
BPS fee.  Only 5% reported a one-time pay bonus.  There may be some increase 
occurring in willingness by employers to recognize and value the BPS certification, 
but it appears to be minor compared to previous periods.
63
   
 What, then, would motivate a pharmacist to exert the time, effort and money 
to obtain this certification, given the fact that it is not required for him or her to obtain 
or maintain employment and that there may be few work-related rewards after 
completion?  A discussion of motivational theories may offer some direction in 
answering that question. 
 
Motivational Theories 
 Motivational theories are classically divided into two major categories.  These 
are content and process.
10
 Content theories are based on the assumption that all 
individuals possess a given set of needs.  Process theories stress the differences in the 
individual’s needs and are more related to the human cognitive processes that create 
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differences.  The four primary content theories are Maslow’s theory, The Existence, 
Relatedness and Growth (ERG) theory, Acquired Needs theory, and Herzberg’s two-
factor theory.
11
  The three primary process theories are Equity theory, valence-
instrumentality-expectancy (VIE) theory, more commonly called Expectancy theory, 
and Goal-Setting theory.
10
 Additionally, Reinforcement theory, also commonly 
classified into process theories, seeks to explain the role of rewards and how those 
rewards may lead to changes in behavior.  These basic types of theories vary in their 
scope. Some of these theories seek to explain human behavior while others are 
focused entirely on workplace motivation.  Simply put, content theories seek to 
explain what motivates us, process theories seek to explain why and how we are 
motivated, and reinforcement theory, a subset of process theories, seeks to explain 
how outcomes influence behaviors.  For the purposes of this discussion psychological 
theories related to organizational motivation and job satisfaction alone are omitted in 
favor of focusing on those theories that may have application to personal motivation.    
To better understand what factors may be affecting pharmacists in their decision to 
pursue or not to pursue board certification a review of each of the theories mentioned 
above follows.   
 
Content Theories – Maslow’s Hierarchy of Needs 
 Some theories of motivation propose a hierarchical approach to explaining or 
describing a transitional approach to motivation.  Abraham Maslow was a pioneer in 
this type of approach and indeed one of the early promoters of the field of self-
actualization
65
.  His initial work in 1943 synthesized many fragments and smaller 
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theories into a more cohesive framework.  This was later updated by Maslow and 
Lowery in 1998 to explain “growth levels” and again in 1971 to identify some more 
differentiation at the higher levels formerly titled “self-actualization”.
65, 66
  The final 
components of Maslow’s work from 1943-1971 demonstrate a pyramid of effects that 
posit that humans go through a progression of states to reach the higher levels.  The 
stages, listed from the lower to the higher are:
11, 65
 
1. Physiological Needs (hunger, thirst, sexual, comforts, etc.) 
2. Safety Needs (security, out of harm’s way, no fear, etc.) 
3. Belongingness and Love Needs (being accepted, approval of peers) 
4. Esteem Needs (achievement, accomplishment, etc.) 
5a. Cognitive Needs (to know, to understand, to explore, etc…) 
5b. Aesthetic (symmetry, order, beauty, etc.) 
6a. Self-actualization (self-fulfillment, realization of potential, etc.) 
6b. Self-transcendence (connection to a greater good, assisting others with 
self-fulfillment, self-actualization or self-transcendence)  
 These values are traditionally arranged in a pyramid, with the higher numbers 
at the top of the pyramid and the lower numbers at the bottom, and is often called 
Maslow’s “pyramid of needs”.  This theory has been widely reviewed and accepted 
by many despite a lack of empirical evidence that any of the segments are in fact 
distinct, or that the progressions must occur linearly.  Some suggest that Maslow’s 
concepts of self-actualization and transcendence are perhaps the most important 
contributions to the study of human behavior and particularly motivation.
65
 Others 
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have attempted to modify and improve upon Maslow’s work and these are discussed 
below.   
 
Content Theories – ERG (Existence, Relatedness, Growth) Theory 
 Clayton Alderfer took the results of studies done on Maslow’s work and 
developed a similar and comparable structure, albeit more simplified.  He called this 
the existence, relatedness and growth (ERG) theory.
11, 67, 68
  Contrary to hierarchical, 
i.e. progressive nature of the component sections of Maslow’s pyramid, Alderfer 
posited that existence, relatedness and growth needs existed simultaneously and may 
vary for each person.
11, 67-69
  An important contribution from the ERG theory is that it 
was recognized that a frustration-regression principle could occur, i.e. if a person did 
not achieve a higher level and remained unfulfilled then that individual might regress 
to an easier and more comfortable level.  This is an important concept as it speaks to 
positive and negative work place motivation.
11, 69
    
 
Content Theories – Acquired Needs Theory 
 David McClelland proposed that a person’s needs are acquired over time.  
These needs are specific to the individual and are shaped by experiences in life.  The 
needs fall into three categories which are the need for achievement (nAch), the need 
for power (nPower) and the need for affiliation (nAff).
11, 68, 70
  The need for 
achievement should increase the desire to do things better, work more efficiently, 
solve problems, master complex tasks or other measures of measurable achievement.  
Persons high in nAch prefer to work alone or with other high achievers and take 
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personal ownership of results.  They prefer achievable goals and will seek things that 
are challenging as long as they are perceived as doable.  Regular feedback is 
important to this group. 
11, 68, 70
   
 There are two types of power addressed with the nPower category. These are 
social or institutional power and personal power. Persons with high personal nPower 
are likely to be controlling of other persons by influencing their behavior and perhaps 
will become responsible for the work of others.  This trait is generally perceived as 
undesirable.   Those with high social nPower use organization as a means to further 
their goals, which are generally the goals of the social group.  This trait is generally 
perceived as desirable and is in fact a sought after trait for managers within 
organizations.
11, 68, 70
  The third category of needs is nAff.  This speaks to the need for 
affiliation.  Individuals with high nAff tend to work toward creation of harmonious 
relationships and seek to establish and maintain relationships.  People with high nAff 
will generally conform to the needs of their work or social group.   
 McClelland developed a test called the Thematic Apperception Test (TAT). 
The TAT is a test of imagination and is based on ambiguous pictures and the 
subject’s ability to spontaneously develop a story about each picture.  Scoring with 
this instrument has been refined to test individuals to determine types of jobs for 
which an individual may be best suited.
70
    
 
Content Theories – Herzberg 
 Frederick Herzberg studied employees in the workplace to determine factors 
leading to satisfaction and dissatisfaction.  He published his findings in 1959 in The 
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Motivation to Work.
71
  Herzberg found that job dissatisfaction and job satisfaction 
were not just different ends of a scale but were in fact a set of independent factors.  
He labeled those factors having to do with job dissatisfaction as hygiene factors and 
those related to job satisfaction as motivators or motivational factors. 
11, 68, 71, 72
  These 
two groupings of factors are known as the two-factor theory although it really is two 
primary factors, hygiene and motivational factors, that are comprised of many sub-
factors.   
 The top six hygiene factors are:
68, 71, 73
   
1. Policies and rules,  
2. Supervision, 
3. Relationship with supervisor,  
4. Relationship with peers, 
5. Base salary or wages, 
6. Working conditions. 
 The top six motivators or motivational factors are:
68, 71, 73
 
1. Achievement, 
2. Recognition, 
3. Work itself, 
4. Responsibility, 
5. Advancement,  
6. Personal growth. 
 Herzberg’s theory has critics.  Job satisfaction does not necessarily indicate or 
imply a high level of motivation.
73
  His assertion that true motivation comes from 
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within the individual however does seem to be an overarching take-away from his 
perhaps difficult to confirm factor interactions.    
 
Process Theories – Equity Theory 
 Equity theory, also known as Adam’s Equity Theory, developed by John 
Stacy Adams in 1963, is based on a perceived sense of equity, i.e. people are happiest 
in relationships where the inputs they bring to a job and the outcomes that they 
receive from those inputs are the same as that of others .
11, 68, 74, 75
  Equity theory also 
has application to personal relationships where the give and take aspects of the 
relationship must be perceived to be equitable or dissatisfaction or distress will occur.  
Whether focused on personal relationships or job satisfaction, equity theory proposes 
that motivation that comes from the outcomes or outputs from the company, project, 
or task must have tangible and intangible aspects that are in balance with the 
inputs.
11,68, 75
  In essence, the referents for comparison are our friends, colleagues, 
family, competitors, workplace superiors and inferiors, and it is by these that equity is 
evaluated.     
 Critics of Equity theory argue that the model is too simple to explain many 
real world interactions of complex factors.
75
  A reasonable summary of Equity theory, 
as it could have application to this study, is that individuals could equate value of 
rewards to effort and compare those values to other people, in effect making 
motivation perhaps based on competition.
11
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Process Theories – Goal-Setting Theory 
 Goal-Setting Theory was developed by Edwin Locke.  It is based on a simple 
premise.  Properly set and managed goals can be motivating.  Goal-setting theory has 
four major components which are difficulty, specificity, acceptance and 
commitment.
4, 11, 76, 77
  This theory focuses on specific motivations that are task based.  
Feedback and reward are principal aspects of this theory.  Feedback is important to 
reinforce progress made toward goals.  Reward is anticipated and interim rewards 
often are defined as goals building toward a larger goal.  The realm of sports is an 
area where goal setting theory has application.  It is also the underpinning for the 
modern management by objectives (MBO) tool common in the business world.
11, 68, 78
    
 Goal setting theory as an abstract concept could have an explanatory value for 
individual motivation to achieve things.  No sound mathematical model to evaluate 
different interactions and relative weights to the different types of goal and rewards 
based on this theory was found in the literature.  
 
Process Theories – Expectancy Theory 
 Expectancy theory is covered in detail later as it is the basis for the survey 
instrument design and metrics for this study.  It is classified as a process theory but it 
also brings together many aspects and elements of both content and process theories. 
 
Process Theories –Reinforcement Theories/Operant Conditioning 
 B.F. Skinner proposed the concept of operant conditioning which is now 
commonly referred to as Reinforcement theory.  This theory explains the role of 
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rewards, or reinforcements, as they cause behavior to change or remain the same over 
time.  Since rewards can be both positive and negative within this theory 
consequences and rewards are sometimes used interchangeably.
11, 68
 
 There are four operant conditioning strategies according to this theory. They 
are positive reinforcement, negative reinforcement, punishment and extinction.   
 Two are intended to strengthen a behavior.  Positive reinforcement is the 
process of the getting something for doing something paradigm.  Frequency or quality 
of a behavior then is increased as consequences of that behavior are rewarded.    
Negative reinforcement is the process of strengthening a behavior by the removal of 
some undesired consequence.  Frequency or quality of a behavior is increased as 
negative consequences, also called stressors, diminish.  
 The other two operant conditioning strategies are intended to weaken a 
behavior.  Extinction is the process of getting nothing for doing something.  Extra 
effort means no additional rewards or basically no reward period.  Extinction 
decreases the frequency or quality of a behavior.  Punishment is the process of being 
punished for a behavior.  If you do an undesired behavior there will be a 
commensurate punishment or removal of a pleasant consequence.
68
 
 In addition to the operant conditioning strategies there are two types of 
reinforcement schedules. The first of these is the continuous reinforcement schedule 
where each time a desired behavior is performed there is reinforcement or reward. 
The second is the intermittent reinforcement schedule. This schedule has fixed and 
variable categories.  These categories are the fixed-interval schedule, fixed-ratio 
schedule, variable-interval schedule and the variable-ratio schedule.  The fixed 
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interval schedule provides reinforcement after some predefined time period has 
elapsed.  The fixed-ratio schedule provides reinforcement after a predefined number 
of desired actions or responses.  The variable-interval schedule provides 
reinforcement after varying amounts of time have elapsed and the variable-ratio 
schedule provides a reward after varying amounts of correct responses or actions have 
occurred.
11, 68
   
 Reinforcement theory has some place in understanding individual motivation 
from an abstract aspect.  It does explain the concept of reward for behavior or lack of 
reward for no desired activity.  It is probably better suited for an organizational 
approach to motivation than one to describe individual motivation.   
 For the purposes of this study it was desired that pharmacists’ perceptions at 
some point in time be measured and operant conditioning theory works better to 
describe overall behavior over some time period.         
 
Expectancy Theory as a Basis for Survey Design 
Valence-instrumentality-expectancy (VIE) theory, as noted above, is a major 
theory of motivation and work behavior.  It may also be called Expectancy-Valence 
(EV), instrumentality theory, and path-goal theory.  The three major variables are 
expectancy, instrumentality and valence (value)
10
 so VIE is commonly used as a title 
for this theory.  It is a process theory in that it seeks to identify the relationship 
between the variables in a dynamic state as they affect individual behavior.  Vroom, 
the initiator of VIE theory postulated that what was crucial to motivation at work was 
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the perception of a link between effort and reward.  In this theory, the relationships 
between the inputs are more the focal point than the inputs themselves.
12
   
 Expectancy theory has applicability to the evaluation of motivation for 
pharmacists choosing to pursue board certification.  The purpose of this theory is to 
evaluate possible connections between expectations of effort to performance, 
instrumentality of the performance to outcomes, and the valences (or values) that 
individuals ascribe to those actions.  It also addresses instrumentality as the perceived 
probability of a performance leading to a desired outcome.  Instrumentality is 
therefore sometimes also called cognized instrumentality.
12
 
 It may seem intuitive that financial inducements would increase interest in the 
pursuit of Pharmacy practice specialization, but at what point does this occur?  While 
this may seem reasonable, there is no definitive evidence that financial rewards are 
the critical or most significant motivating factor.  Other factors related to career, 
personal concerns, and professional standing may have an equal or greater impact on 
decisions.  More likely, combinations of factors within these four proposed domains, 
and potentially the interactions among the domains, may be involved with the 
motivation to pursue or not pursue board certification for pharmacists. 
 There are two key concepts at the base of Expectancy theory.  The first is that 
“…the valence of an outcome to a person is a monotonically increasing function of 
the algebraic sum of the products of the valences of all other outcomes and his 
conceptions of its instrumentality for the attainment of these other outcomes.”
12
   
 This can be expressed mathematically as:
12
 
 
 39 
         n 
     Vj = fj     ? (VkIjk)    (j =1…n)                                (Eq. 2-1) 
                                 k = 1 
 
 
fj? > O: i Ijj=O 
 
Where Vj = the valence of the Outcome j 
Ijk = the cognized instrumentality (-1 ? 1jk ?1) of outcome j for the attainment of 
outcome k. 
With the assumption that choices made by people are inherently and 
subjectively rational, the second major assumption is that “…the force on a person to 
perform an act is a monotonically increasing function of the algebraic sum of the 
products of the valences of all outcomes and the strength of his expectancies that the 
act will be followed by the attainment of these outcomes.”
12
  This can be expressed in 
the following equation:
12
  
                                  n 
                                        Fi = fi        ? (EijVj)    (i = n + 1…m)                         (Eq. 2-2) 
                                                      f = 1 
 
 
fi? > O: i ? j = ?, ? is the null set 
Where Fi = the force to perform act i 
Eij = the strength of the expectancy (O ? Eij ? 1) that act i will be followed by 
outcome j 
Vj = the valence of outcome j 
∩ = Intersection 
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This equation can also be written more simply as: 
 
             n 
                                F  =  ? (EiVi)                                                  (Eq. 2-3) 
         t  = 1 
 
 
The value Ei has two components.  One is the effort-to-performance expectancy (E ? 
P).  The second is the performance-to-outcome expectancy (P ? O) which is also 
known as instrumentality.
72, 79
  This can be mathematically expressed, in VIE terms,  
as:
12
 
                                F  =  ?   (E?P) x ?  (P?O) (V)                               (Eq 2-4) 
 
Where, (E?P) =Expectancy, (P?O) = Instrumentality, and V =Valence (Value).  
  From the example shown in Figure 1-1, and utilizing the derived formula in 
Equation 2-4, the value of the motivational force to pursue a position, certification or 
additional qualification (or effort that is willing to be expended) can be calculated by 
adding the values of the valence and the instrumentality calculations (products) and 
multiplying the total by the expectancy value.   
 If we review the data from Figure 1-1 we find that the values discussed and 
represented as decimal equivalents were: 
• Expectancy = 0.5 
The performance-to-expected reward instrumentalities were:  
• Performance to pay raise = 0.9 
• Performance to promotion = 0.5 
• Performance to longer holiday = 0.3 
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• Performance to company car = 0.6 
Valences or values were: 
• Pay raise = 6 
• Promotion = 8 
• Longer holiday = 5 
• Company car = 9 
 The instrumentality and valence products summed are: 
(0.9 x 6) + (0.5 x 8) + (0.3 x 5) + (0.6 x 9) = 16.3.  With the result multiplied by the 
expectancy of 0.5 this yields 8.15 based on 16.3 x 0.5.
10
  The decimal equivalents are 
typically seen but the whole number equivalent can be used as well. The only change 
to the result is the order of magnitude.  For example, using the numbers just listed but 
substituting whole numbers we see  (9 x 6) + (5 x 8) + (3 x 5) +(6 x 9) = 163,  and 
163 x 5 = 815.  So the formula is reduced to the sums of instrumentality multiplied by 
the value sums and then multiplied by the expectancy, or Motivation = Expectancy x 
Instrumentality x Value (M = E x I x V).   
 In the classical use of the expectancy theory formula, zero values are allowed 
but the expectancy (expectancy-to-performance, E?P), instrumentality (P?O, 
performance-to-outcome, valence (value) must all have at least one value greater than 
zero or the resultant calculation leads to zero.      
 This is the numerical representation of the force of motivation.  With a 
numerical result calculable, the potential to mathematically compare various persons 
or groups exists.  Rather than relying on complex statistical comparisons a rapid 
mathematical comparison of motivational force and categorization can be performed.   
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 The result of the VIE calculation has no independent value.  However, results 
of multiple VIE calculations, which are measures of motivational force, have 
comparative value.  It was for this reason that a survey instrument was developed 
based on this mathematically based theory and that the methodology described in the 
next chapter utilizes it as underpinning for the study. 
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Chapter 3. Methodology 
 
Purpose 
 The primary purposes of this study were to: (1) compare the benefits and 
rewards (instrumentalities) that are perceived as most important by pharmacists with 
regard to board certification by BPS, (2) compare the most valued aspects or factors 
perceived by pharmacists with regard to board certification, (3) evaluate the 
relationship between instrumentalities and values, (4) determine if a certain set of 
factors was more prevalent in board certified pharmacists than those that were not,  
(5) compare the calculated force of motivation between board certified and non-board 
certified pharmacists and, (6) evaluate if there was a tipping point where a certain 
combination of factors would be present in board certified pharmacists that were 
greater than non-board certified pharmacists.  This latter point was defined as a 
marked difference in overall score on the VIE scale, or calculated force of motivation 
(MF), on the survey instrument. 
 
Research Design 
 This research was designed as a prospective internet survey employing an 
exploratory descriptive design.  Participants that agreed to participate in the study 
were asked to respond to a series of survey items related to probability of occurrence 
of an event stated and the importance or value to them of that event or action.  
Additionally, the respondents were asked a question regarding their anticipated 
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success rate given that the effort was put forth.  The survey instrument was unique in 
design in that multiple levels of answers to the same statement were required.   
 Summary and descriptive statistical measures were used to evaluate means, 
variance and other related aspects of the study population.  The primary statistical 
marker was the Student’s t-test
80
 as a comparative measure for all variables between 
pharmacists that were board certified and those that were not.  For the purposes of 
this study a significance level of p < 0.05 was established.  Included in this evaluation 
was a determination of a threshold level, i.e. the level that motivational force, 
measured as an overall score based on the collective individual scores, caused 
individuals to take action.     
 A survey instrument titled “Advanced Certification Index for Pharmacists”  
(ACI-P) was developed for this study. There were three levels of items to be 
addressed via the survey instrument. These were instrumentality, valence and 
expectancy.  Instrumentality is an individual’s anticipated probability of an event 
occurring.  Valence, also known as value, is a measure of the value or importance to 
the respondent of that particular item, question or statement.  Expectancy is a measure 
of the respondent’s belief that an action or series of actions will lead to a successful 
outcome.  In this case the outcome was attainment of specialty certification in one or 
more of the five identified Pharmacy practice specialties. 
 The survey instrument design used an a priori determination of domains as a 
means to fashion the item sets.  The intent of this research was not to prove or 
substantiate those domains but rather to evaluate the item sets and compare the 
generated responses. 
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Settings and Subjects 
 The study was completed via the internet.  Respondents hailed from various 
practice settings including private pharmacies, hospitals, academia, specialty 
pharmacies, government, and large chain/company owned pharmacies.  Due to the 
fact that specialty certification may not have been a job requirement in a majority of 
settings, but may have been in others, the practice setting of the individual may have 
contributed to the individual’s opinions.   Access to computers and assurance of 
anonymity of the respondent was important.  The study setting allowed for remote 
access, i.e. home, library, or other portal into the data collection mechanism.  The 
internet protocol (IP) address for the computer used by the respondent was not 
captured.  This can be captured automatically by survey tools but was deliberately 
omitted for the purposes of this study to assure anonymity of respondents.  
 The study group included currently BPS board certified members from the 
five specialties, those that were not currently board certified, and those that had never 
been board certified that were members of one or more of the American Society of 
Health-System Pharmacists (ASHP), American Pharmacists Association (APhA), the 
American College of Clinical Pharmacy (ACCP), the American Association of 
Colleges of Pharmacy (AACP) and the Board of Pharmaceutical Specialties (BPS).  
Former board certified pharmacists that had not renewed their certification were 
considered for the comparison and their responses were included with the ones that 
were not board certified.  Information that was gleaned from this research will be 
shared with the Board of Pharmaceutical Specialties and other professional 
organizations as summary information only.   
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Inclusion Criteria 
 All pharmacists practicing in any practice setting were eligible to participate.  
The focus was directed toward members of APhA, ASHP, ACCP, AACP and BPS.   
However, since dissemination of the survey link was also to non-members of any of 
these organizations, via word of mouth or secondary electronic transmission to 
colleagues, any practicing pharmacist was eligible to participate whether a member of 
an organization or not.   
 
Exclusion Criteria 
 Non-pharmacists were not to complete the survey and if they did their data 
was excluded.  
 
Sample Size 
To determine a sample size needed for the study a technique was established 
as the primary statistical method for evaluation.   This was the Student’s t-test.  Using 
a methodology developed by Cohen known as the Cohen’s “d”, sample size estimates 
were made.
81
  The Cohen’s d procedure for sample size determination is adequate 
even when the standard deviation (sigma) of a population is unknown.  These 
estimates or projections were made based on an unknown sigma on two independent 
means.  Effect size, as defined by Cohen, is the difference in means between two 
groups divided by the standard deviation.
81
   Interpretation of the Cohen’s d allows a 
differential when comparing statistical significance versus practical significance.  One 
way of looking at the comparison of effect size is to consider d = 0.0 to 0.2 as a trivial 
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effect size, d = 0.2 to 0.5 as a small effect size, d = 0.5 to 0.8 a moderate effect size 
and d > 0.8 to be a strong effect size.  Or, more commonly, 0.2 = small effect, 0.5 = 
moderate effect and 0.8 = strong effect.
81
  In other words, if one expects a more easily 
discernible effect (a strong effect) a 0.8 would be the choice and if one were to expect 
the effect to be small then the 0.2 would be the choice for the Cohen d classification.  
Using tables based on Cohen’s d, three sample size potentials were found and 
are listed in Table 3-1.  
Since there were no assumptions about the effect size that could be expected, 
a sufficient sample size was projected to determine the smallest possible effect size so 
790 was the projected sample size with at least 395 occurring within the board 
certified group and at least 395 occurring in the non-board certified group.  To 
account for incomplete or missing data, actual projections were escalated by 20% 
higher than these numbers, therefore it was estimated that 474 (1.2 x 395) would be 
needed for each group.  To attain the large numbers needed for this study four of the 
large Pharmacy organizations and the Board of Pharmaceutical Specialties were 
requested to contact their membership electronically and solicit participation.   
Exploratory factor analysis and parallel axis analysis were used to evaluate 
like factors and determine the underlying constructs, or commonly associated items, 
within the data.   It must be pointed out that although confirmation of stated or 
particular factors can be useful for many survey instruments, the purpose of this 
research was not to prove or disprove the a priori proposed domains, and therefore 
confirmatory factor analysis was not attempted. These a priori domains were helpful 
in creation and stratification of the questions for the survey instrument.   
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Table 3-1.   Sample Size Projections Based on Cohen’s d Estimates, Effect Size is an  
 Estimate of Discernible Effect  
 
Effect Size 
Group One  
Subjects 
Group Two  
Subjects 
Total  
Subjects 
0.2 395 395 790 
0.5 65 65 130 
0.8 27 27 54 
Note: An effect size of 0.2 means a difficult to discern effect, 0.5 and 0.8 mean 
medium and easy to discern effects, respectively. 
 49 
To calculate a sample size for exploratory factor analysis or parallel analysis, 
in order to evaluate relationships among the questions on the survey, ten responses 
per question were necessary.  Much debate in the literature has focused on an 
appropriate subject-to-item ratio with the lower level seen at 2:1 and the upper end at 
100:1. However, 63% of studies evaluated have used 10:1 or less with the 10:1 ratio 
still considered a prevalent rule of thumb for a priori evaluations of sample size.
82-84
  
With a survey totaling 51 items, not including demographics, that translates to a 
sample size of 510 subjects.   However, since there are 25 question sets each of the 
subsets could be considered an independent set for the same issue which means only 
260 responses would be necessary.  This included the additional question regarding 
expectancy (25 + 1 x 10 = 260).   
Some assumptions of data lost similar to those mentioned under the Cohen’s d 
projection were factored in to increase the projected need of 260 by 20% to 312 total 
respondents needed. However, utilizing the small effect calculation via Cohen’s d, a 
sufficient sample size would have been attained for factor and parallel axis analysis.   
 
Sample Description 
The investigator obtained demographic information that was completed by the 
respondents.  The demographic information included age, gender and an additional 13 
items summarized from the five separate board certification tests currently in use by 
the Board of Pharmaceutical Specialties for their Pharmacy Examination 
Demographic Survey, which accompanies the component of the Certification 
Examination for Board Certification in any specialty area in Pharmacy.
85
  The 
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demographic responses were not required of the respondent although this information 
was requested to compare findings of this survey with those done previously by BPS.  
The demographic findings and relationships were pertinent but were not a focal point 
of the study.    
The included items in the demographic and BPS survey alignment for this 
project, minus the responses, are listed below.  These retain original wording where 
possible from the BPS surveys.  The demographic and BPS survey alignment section 
followed the primary questions on the survey. 
1. Age. 
2. Gender. 
3. What is your current board certification status? List all that apply. 
4. What is the CITY of your PRIMARY practice setting? 
5. What is the STATE, TERRITORY or LOCATION (e.g. international 
work location) of your PRIMARY practice setting? 
6. Which of the following most closely classifies your position at your 
primary practice setting?  Multiple answers are allowed but please limit to 
two. 
7. What is the average number of hours you typically work each week in the 
practice of Pharmacy? 
8. What was your ENTRY LEVEL Pharmacy-related degree? 
9. What is the HIGHEST Pharmacy-related degree you have earned? 
10. If you earned a Pharm.D. degree, please indicate the TYPE of Pharm.D. 
program. 
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11. Have you completed a residency training program? 
12. In total, how many years have you worked full- and/or part-time as a 
licensed pharmacist? 
13. In total, how many years have you worked full- and/or part-time in your 
current area of specialty or practice focus? 
14. Indicate your PRIMARY reason for seeking board certification. 
15. Indicate a SECONDARY reason for seeking board certification. 
16. List Pharmacy organizations to which you belong. 
 Additionally the respondents were asked to respond to twenty-five different 
sets of two questions or statements.  These two set questions were divided into PVI 
groups (PVIGs).  For each instrumentality response statement, the part “a” of the 
statements/questions (items) addressed the instrumentality related to that factor or 
aspect.  This was the probability of that factor or aspect occurring as perceived by the 
respondent.  Part “b” of the item set was related to the value (valence) an individual 
held for that particular aspect.  The item sets were numbered and had a part “a” and 
“b” to reduce confusion.  They were organized in such a way that, except for question 
26 and higher, each was a set involving an instrumentality question (probability of 
occurrence) and valence (value) component, in that order. 
 High instrumentality does not indicate high valence and low instrumentality 
does not indicate low valence.  The opposite may well be true.    
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Instrumentation 
 The survey instrument titled “Advanced Certification Index for Pharmacists” 
(ACI-P) which was developed for this study records three primary response types 
within the context of the design.  All responses were answered using a Likert type 
five-point scale with the lower end identified as “Will definitely not occur” and the 
upper end identified as “Will definitely occur” on the instrumentality (perceived 
probability) questions.  The value (valence) questions had a scale with the lower end 
identified as “No value” and the upper end as “Highly valuable”.   Each lower end 
was treated statistically as a “1” and each upper end was treated as a “5”.  Both scales 
had an identified neutral point.  The utilization of these scales shaped the VIE theory-
based instrument into a non-zero environment, which means that zeros, which can 
cause problems with the calculations, were eliminated.  Also, since it was posited that 
the absolute value of the VIE calculation had no true definition or baseline, relative 
metrics were more important.  By using a non-zero scale and using the whole 
numbers of the 5-point scale a useful scoring methodology was employed.  
 With all demographics and ACI-P specific questions the total number of items 
was sixty-seven (16 + 51 = 67).  This was a lengthy survey but could be completed in 
about 15 minutes utilizing the on-line/internet format.  Demographic questions were 
included at the end of the survey to prevent possible survey fatigue from interfering 
with the most needed responses from the instrumentality and valence sections. 
The ACI-P was modified to fit an internet-only approach.  This is discussed in 
more detail below under Internet Survey. 
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The instructions for the ACI-P Survey Tool were listed on page one of the 
web survey tool.  They read:  
This survey seeks your opinions on the factors that may influence a pharmacist’s 
decision to seek board certification in a Pharmacy specialty. The survey should take 
no more than 15 minutes.  
 
Your input is important whether you have no intention of pursuing board 
certification in Pharmacy practice, intend to pursue in the future, have already 
completed the certification or were previously board certified.   
 
This survey is based on two components of each factor that may be related to pursuit 
of specialty certification in Pharmacy practice.  These components are:  1) the 
probability of occurrence as you perceive it, and 2) the value of that particular factor.  
 
Definitions: 
For the probability of occurrence (the first part of each question) the scale is a 
measure of perceived probability with the lower end “Will not occur” being the 
lowest probability of occurrence and “Will definitely occur” being the highest.  
 
For the value assessment, the lower end value of “No value” means the lowest value 
to you as a pharmacist and “Highly valuable” means the highest value to you. Please 
check the corresponding bubble for each selection.  
 
All questions are related to pursuit and achievement of board certification in 
Pharmacy by the Board of Pharmaceutical Specialties.  An asterisk (*) next to a 
question means a response is required and only applies to the first 26 questions.” 
 
Additional Information: 
There are 16 demographic questions at the end of the survey that will be used in 
comparing this information with what has been collected by the Board of 
Pharmaceutical Specialties in previous surveys.  
 
This study has been approved by the University of Tennessee Institutional Review 
Board.  There is no consequence for refusing to take the survey or any direct benefit 
to you other than professional value to Pharmacy in general.  Your identity will not 
be disclosed and no relational information regarding your demographics information 
will be attempted.  The scope of this study is to characterize aggregate trends and not 
those of an individual.  Summary data only will be made available to Pharmacy 
organizations.  The results of this survey may be presented at a professional meeting, 
become published or become part of a Ph.D. dissertation.   
 
Consent for Participation: 
This survey is voluntary. By proceeding with this survey I consent to participate. 
 
 The questions on the survey were arranged so that each value (valence) 
question was listed at the same time on the computer screen with the instrumentality 
(perceived probability of occurrence).  These were the Perceived Valence 
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Instrumentality groups (PVIGs) described above and were important considerations 
for data evaluation.  Some value questions were so basic to the human condition that 
it was expected that most of the responses would be on the high end.  However others 
were expected to have considerable variance.  Not aligning the benefits to the 
pharmacist with highly regarded values could be problematic and where they do not 
align was an important finding of the study.  For this reason one variable within the 
PVIG analysis was the result of subtracting the instrumentality from the value. 
 The questions were designed based on a priori proposed domains.  These four 
proposed domains were professional, personal, career and financial with the 
understanding that the lines of distinction between these were not clearly defined and 
that these domains may not have existed as separate constructs.  Item to domain 
relationships were proposed and are listed in Table 3-2.  The domains were not 
equally represented by numbers of items and career and financial aspects were the 
two most highly represented of the domains.  It was thought that these may be more 
influential and more items were added in these sections to more fully characterize 
these elements. 
 Item sets were arranged with specific Perceived Value Instrumentality groups.  
The PVI groups and survey questions are listed below.  The Perceived Valence 
Instrumentality groups are helpful to understand some discussions in Chapter 4.  The 
PVI group headings are listed with the designated item group as follows: 
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Table 3-2.   Proposed Domains of ACI-P, Questions within Domains and 
Percentages of Total 
 
Domain Item Sets Percentage of Total 
Professional 4,5,11,16,24 5/25=20% 
Personal 1,10,17,18,23 5/25=20% 
Career 2,6,7,8,13,19,22,25 8/25=32% 
Financial 3,9,12,14,15,20,21 7/25=28% 
Expectancy 26 N/A 
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1. Self image 
a. My self image will be improved by becoming board certified. 
b. I value my self image. 
2. Employable 
a. I would become more employable if I were board certified. 
b. I value becoming more employable. 
3. Higher salary 
a. I will receive a higher annual salary if I am board certified. 
b. I value a higher annual salary 
4. Professional opportunities 
a. My professional opportunities will improve with board certification. 
b. I value professional opportunities. 
5. Peer respect 
a. I will have increased peer respect by becoming board certified. 
b. I value peer respect. 
6. Career advancement 
a. My career will be positively advanced by becoming board certified. 
b. I value career advancement. 
7. Academic opportunities 
a. My academic opportunities will improve if I am board certified. 
b. I value academic opportunities. 
8. Downsizing protection 
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a. In a workplace that is downsizing, board certification will protect my 
job 
b. I value a protective effect from downsizing. 
9. Initial costs 
a. My initial certification costs will be paid by my employer. 
b. I value my initial certification costs being paid by my employer. 
10. Credibility 
a. Board certification credentials will add credibility to my opinions. 
b. I value credentials to improve my credibility. 
11. Professional respect (Colleagues) 
a. Other practitioners within my profession will respect my board 
certification status. 
b. I value professional respect from my colleagues. 
12. Annual salary increases 
a. If I am board certified I will receive higher annual salary increases. 
b. I value higher annual salary increases. 
13. Hiring influence 
a. I would hire a board certified practitioner over another non-board 
certified practitioner with otherwise equal qualifications. 
b. I value board certification enough to positively influence a hiring 
decision between candidates with otherwise equal qualifications. 
14. Financial incentive to SEEK board certification 
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a. Increased financial incentive from my employer would cause me to 
SEEK board certification status. 
b. I value a financial incentive from my employer based on SEEKING 
board certification. 
15. Financial incentive to MAINTAIN board certification 
a. Increased financial incentive from my employer would cause me to 
MAINTAIN board certification. 
b. I value a financial incentive from my employer to MAINTAIN board 
certification status. 
16. Non-professional co-workers’ respect 
a. Non-professional co-workers will respect board certification status. 
b. I value non-professional co-workers respect of board certification status. 
17. Practice skills confidence 
a. I will have increased confidence in my practice skills as a result of being 
board certified. 
b. I value increased confidence in my practice skills. 
18. Personal accomplishment 
a. I will feel a sense of personal accomplishment by becoming board   
certified. 
b. I value personal accomplishment demonstrated by a board certification 
credential. 
19. Increased responsibility 
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a. I will have increased responsibility in my job role after becoming board 
certified. 
b. I value increased responsibility in my job role. 
20. One time bonus 
a. I will receive a one time pay bonus upon completion of board 
certification. 
b. I value a one time pay bonus for completion of board certification. 
21. Paid certification costs 
a. My recertification costs will be paid by my employer. 
b. I value that my employer would pay my recertification costs. 
22. Promotion potential 
a. I will be more likely to be promoted by my employer by employer if I 
am board certified. 
b. I value promotions based on board certification. 
23. Public notification 
a. There would be a public notification of my achievement and status if I 
become board certified. 
b. I value a public notification of my achievement and status. 
24. Improved professional network 
a. I would have an improved professional network by becoming board 
certified. 
b. I value an improved professional network. 
25. Job requirement 
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a. Board certification will become necessary for my job. 
b. I value that my job will require board certification. 
 The following information was included as directions preceding Question 26 - 
Expectation.  
 “This section is based on your opinion of the likelihood of completion of 
board certification upon expenditure of the effort.  If you have no intention of 
pursuing board certification in a Pharmacy practice specialty please answer question  
26.a.  Please answer N/A as needed. 
26. Expectancy 
c. I am NOT currently board certified but I feel that if I expended the effort 
I would successfully complete the board certification process. 
d. I AM currently board certified and PRIOR TO BEGINNING 
preparation for specialty certification I felt that if I expended  the effort I 
would successfully complete the requirements for board certification. 
e. I WAS formerly board certified and PRIOR TO BEGINNING 
preparation for specialty certification I felt that if I expended the effort I 
would successfully complete the requirements for board certification.” 
 
Delphi Panel–Pilot Study 
 The ACI-P was presented to and evaluated by a Delphi panel-pilot study to 
establish face and content validity.  This panel was made up of the faculty at the 
University of Tennessee College of Pharmacy and other faculty associated with the 
University of Tennessee College of Pharmacy.  There were twenty one respondents to 
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the survey.  Eleven respondents were currently board certified, eight were never 
board certified and two were previously board certified.  No material changes were 
made but two minor wording changes were made to the ACI-P survey instrument as a 
result of the pilot study.  The survey was deployed with an understanding that face 
and content validity was established.  
 
Study Procedures 
 
Subject Identification 
All pharmacists in the United States, whether board certified by BPS or not, 
were subjects for this research.   Since the survey was an internet based instrument, 
access was limited by access to computers and the internet.  Internet connection speed 
may have also been a limiting factor for subjects.  Pharmacy organizations, 
particularly the Board of Pharmaceutical Specialties, American Society of Health-
System Pharmacists, American Pharmacists Association, American College of 
Clinical Pharmacy and the American Association of Colleges of Pharmacy were 
engaged by the investigator and encouraged to distribute the hyperlinks for the survey 
site. Hyperlinks are imbedded computer codes that allow a user to activate those 
links, which are uniform resource locators (URLs), by mouse or keyboard and be 
immediately directed to a location which is defined by the link.  See Appendix B to 
view requests for participation and agreements to participate by the five participating 
organizations. 
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Internet Survey 
Enrollment was open and voluntary.  At no time were the respondents asked 
their name or any personal questions other than demographics.  No tracking of the 
location of the respondents was done and communication of the anonymity measures 
of the survey information was included in survey instructions.  The survey was 
completed by internet at the respondent’s convenience.  The automated approach may 
have made the number of questions less intimidating as the length of the survey was 
long but unknown to the participants at the outset.  The design and completion of the 
survey was completed by using the internet survey tools available at 
SurveyMonkey.com.
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Data Analysis 
Data collected for the study included:  
A. Responses for items of the Advanced Certification Index for Pharmacists 
(ACI-P) as previously described.  
B. Demographics based on previous BPS surveys were collected.  This was 
for comparison purposes to previous studies and was not a primary 
endpoint of the study.    
Data were analyzed via standard statistical analysis which included Student’s  
t-tests, correlational analysis, exploratory factor analysis, parallel axis analysis, and 
internal consistency and reliability measures.   Validation of the survey constructs of 
the ACI-P instrument was completed with factor analysis and verified with parallel 
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analysis utilizing SAS.  Reliability of the ACI-P constructs were established with the 
Cronbach’s alpha reliability coefficient utilizing SAS.
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  There were at a minimum six extreme subsets of the data predicted as far as 
Instrumentality (Probability of occurrence) and Valence (Value): 
a. High instrumentality x high value (sum of the products) 
b. High instrumentality x low value (sum of the products) 
c. Low instrumentality x high value (sum of the products) 
d. Low instrumentality x low value (sum of the products) 
e. Ambivalent instrumentality x ambivalent value (sum of the products 
f.  Large differences in value minus instrumentality (difference) 
 These of course could each be subdivided by various demographic differences 
to achieve other subsets of the data.  Most of the findings fell between these extremes.    
  The VIE calculation, minus the “E” part since it was the same value for any 
individual respondent, became the Valence x Instrumentality score or the VI Score 
(VIS).  Perceived Value Instrumentality groups (PVI groups or PVIGs) provided four 
different responses, two of which were directly reported and two of which were 
calculated. Using “Self Image” as an example the following four variables were seen: 
• Selfimage_P  Probability (instrumentality). This was directly   
     reported. 
• Selfimage_V  Value to the individual. This was directly reported. 
• Selfimage_VIS Instrumentality x value (VIS).  This was calculated.   
• Selfimage_Diff Value – instrumentality.  This was calculated.  
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 The intent of the study was not to prove or disprove VIE theory but rather to 
compare groups to determine if there were differences in instrumentalities and 
valences, as well as expectations, between practicing and qualified pharmacists that 
were board certified and those that were not.  The mathematical model of VIE 
provided a framework to evaluate multiple and interactive forces and perceptions 
simultaneously.  Comparing currently board certified and non-board certified 
pharmacists with these various mathematical findings, based on the VIE model, 
demonstrated motivational factors and calculated motivational force for both groups.  
 
Consideration of Human Subjects 
 This study was designed to determine the motivational forces leading certain 
health care professionals, in this case pharmacists, to seek specialty certification in 
their practice area.  It was based on perceptions of benefits and beliefs of the 
respondents.  Since establishing forces leading to an unrealized or not yet attained 
goal was too complex, a comparison of motivational force and motivating factors 
between board certified and non-board certified pharmacists was completed. 
Participating pharmacists were asked to provide information anonymously via an 
internet portal.   Participation in the study by the pharmacists was voluntary. Exempt 
status was requested and granted by the University of Tennessee Institutional Review 
Board. 
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Chapter 4. Results and Findings 
 
Survey Mechanics and Data Collection 
 The Advanced Certification Index for Pharmacists (ACI-P) was deployed via 
electronic mail and webpage notification by four Pharmacy organizations and the 
Board of Pharmaceutical Specialties in the summer of 2007.  The intent was to begin 
the survey on June 1, 2007 and leave it open for entry until the sample size 
projections needed were met or for a total of six weeks.   Due to some issues with 
several of the organizations’ communication systems, deployment was uneven and 
sporadic at the outset.  Information about the importance, need and a request for 
participation was put forth by APhA, ASHP, ACCP, AACP and BPS.   It was likely, 
and was intended, that this combined effort contributed to a good survey response.  
The collaboration and cooperation of these five organizations contributed 
considerably to both the numbers of respondents, as well as to a good cross section of 
various practitioner types and comparably matched ages and genders. 
 The first survey response was received at 5:38 PM on June 5, 2007 and the 
last survey was received at 8:23 AM on August 7, 2007.  The survey was left open 
longer than the anticipated six weeks due to the slower than expected beginning date 
for several of the organizations and because the continued daily receipt rate was high.  
Total time open was 62 days and 15 hours.   
 In all, 2,274 pharmacists began the survey.  Of those, 2,129 completed all of 
the 25 PVIG sets for a completion percentage of 93.7%.  The question regarding 
expectancy (question number 26) was apparently unclear as 2,095 of the 2,129 
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(98.4%) responded to the question but some answered all, or several, of the options. 
Recoding on this variable required manually comparing the data to demographic 
questions, or to other markers, to determine status of the pharmacist.  Those that 
could not be positively identified as to board certification status were omitted from 
the research data set.  A total of 2,057 of 2,129 completed surveys were retained for 
the research data representing a clean data rate of 96.6% of those completing all 
questions and 90.5% of those initiating the survey (See Table 4-1).  All VIE 
calculations were based on the data set of 2,057 complete surveys.  This data set was 
comprised of 496 (24.1%) non-board certified pharmacists and 1,561 (75.9%) board 
certified pharmacists (See Table 4-2).  Responses from both groups were in excess of 
the calculated 395 per group sample size needed for statistical significance. 
 
Demographics 
 The demographic questions were optional and 1,940 (94.3% of 2,057) 
completed at least the gender question and 1,924 (93.5% of 2,057) completed the age 
question.  There were 1,924 (93.5%) respondents that answered both the age and 
gender questions (A+ G respondents).  The differences in age between genders in the 
sample population were significantly different with the mean of the female 
participants at 42.3 (SD 10.6) and the male participant mean of 37.9 (SD 8.5).  The 
demographic statistics of gender and age are depicted in Table 4-3 and Table 4-4.  
 There was less variance in the age of the board certified pharmacists group 
which may have been due to the larger number of those pharmacists responding.  The  
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Table 4-1.  Distribution of Pharmacist Respondents to 2007 ACI-P Survey 
 
Status Number % of Began Survey 
Began Survey 2,274 100% 
Completed Survey 2,129 93.7% 
Retained Survey Dataset 2,057 90.5% 
ACI-P = Advanced Certification Index for Pharmacists 
 
 
 
 
Table 4-2.   Distribution of Retained Pharmacist Respondents from 2007 ACI-P  
  Survey 
 
Sample Number 
% of Retained  
Responses 
Non-Board Certified Pharmacists 496 24.1% 
Board Certified Pharmacists 1,561 75.9% 
Retained Pharmacist Respondents 2,057 100% 
 ACI-P = Advanced Certification Index for Pharmacists 
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Table 4-3.  Demographics of Respondent Sample in Retained Survey Dataset from  
 2007 ACI-P (N=1924 for Age + Gender [A+G]) 
 
Respondents Number % Mean Age SD 95% CI 
Male 1,176 61.1 37.9 8.5 37.4-38.4 
Female 748 38.9 42.3 10.6 41.5-43.0 
Total 
(Age/Gender) 
1,924 100 39.6 9.6 39.2-40.0 
p value M 
Age/F Age  
p<.0001 (Student’s t test) 
 
 
 
 
Table 4-4.  Respondent Groups by Age, Certification Status and Gender (N=1,924  
 for Age + Gender [A+G]) 
 
 BCP 
Male 
BCP 
Female 
NONBCP 
Male 
NONBCP 
Female 
Number (%) 
892  
(46.4%) 
569  
(29.6%) 
284  
(14.8%) 
179  
(9.3%) 
Mean Age 38.2 42.0 37.2 43.1 
Std Dev 8.3 9.7 9.0 13.0 
95% CI 37.7-38.7 41.2-42.8 36-38.2 42.5-43.7 
Age range 25-62 25-69 22-63 24-80 
BCP = Board Certified pharmacists, NONBCP = Non-Board certified pharmacists 
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range for non-board certified pharmacists was 22 to 80 and for the board certified 
pharmacists the age range was 25 to 69. There were no significant differences in the 
male and female subsets for the non-board certified pharmacists and the board 
certified pharmacists.  However, there were differences among age by gender 
segments.  The overall age mean for all respondents was 39.6 (SD 9.6, 95% CI 39.2 – 
40.0).  Male respondents had a mean age of 37.9 (SD 8.5, 95% CI 37.4 – 38.4) and 
female respondents had a mean age of 42.3 (SD 10.6, 95% CI 41.5 – 43.0).  These 
were significantly different and are depicted in Table 4-3.  
 The means for the ages, plus standard deviations were 39.4 (SD 11.1) for the 
total non-board certified pharmacists and 39.7 (SD 9.0) for the total board certified 
pharmacists.  These were not statistically different (t = -0.49, p > 0.63).  The non-
board certified pharmacists had 284 male respondents (14.8% of A+ G respondents) 
and 179 female respondents (9.3% of A+ G respondents).  The board certified 
pharmacists had 992 male respondents (46.4% of A+ G respondents) and 569 female 
respondents (29.6% of A+ G respondents). Table 4-4 depicts segmentation of the 
pharmacists that answered both the age and gender questions on the ACI-P 
demographic section.     
 Within gender groups, ages were significantly different for males in the non-
board certified and board certified groups with means of 38.2 years of age (95% CI 
37.7 – 38.7] for NONBCP and 37.2 years (95% CI 36 – 38.2).  The female 
comparison showed the NONBCP with a mean age of 43.1 (95% CI 42.5 – 43.7) and 
42 (95% CI 41.2 – 42.8).  These ages were significantly different between groups for 
female pharmacists.  Although these groups were statistically different they were very 
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close from a practical standpoint.  The two male sub-groups were within 1 year of age 
and the two female sub-groups were within 1 year of each other and the confidence 
intervals were very close. 
 Other demographic responses were somewhat sporadic.  In addition to the 16 
demographic questions, a single comment question regarding the pharmacists’ 
opinion of board certification in general was asked and 331 of the 2,274 (14.6%) 
responded.   The final retained dataset contained 324 of 2,057 (15.7%) additional 
comment responses.  Despite the relatively low response rate this provided some 
interesting viewpoints on pharmacists’ perceptions of the current board certification 
process and their opinions of its status.   The response rate may actually have been 
acceptable or appropriate considering it was the last of 67 questions and required free 
text entry.  A full analysis of this separate data set was beyond the scope of this study 
but a categorical stratification of the data was completed and a total of 620 separate 
findings were categorized into 12 groupings.  These are discussed at the end of this 
chapter. 
 The cleaned dataset was large at 6 megabytes (1 megabyte is about the 
amount of information in the text of a 600 page paperback book in the most efficient 
storage method).  The primary and master data table was comprised of 2,057 data 
rows and 120 columns of information related to the VIE components (directly 
reported and calculated) which was 246,840 individual data elements.  In addition, 
there were 53 columns of additional demographic information.  This was a rich 
dataset that may be useful for future research. 
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 Use of the five-point Likert scales for the survey instrument presented some 
options for using a standard survey scale and adapting to the Expectancy Valence 
model (VIE) format.  In the classic sense of the VIE model there can be zero values 
for value, instrumentality or expectancy.  The purposes of this study were not to 
determine an actual or “real” value of motivation or to create a benchmark of value. It 
was to determine how a given set of Perceived Valence Instrumentality group 
components compared.  For this reason, the five-point Likert scales with 1 being 
lowest and 5 being highest, were used for both populations and the usual use of a 
decimal equivalent was not necessary since the numbers were used for comparison 
only.  By observing these two conventions, the zero effect on the product of the 
calculations in VIE was eliminated and a direct measure of statistics compared to the 
ACI-P methodology was made.   
 Utilizing this model, the lowest score that could be made on the ACI-P was 25 
(1 for all valences, 1 for all instrumentalities [25 total for VIS] and 1 for expectancy, 
and the highest score was 3125 (5 for all valences, 5 for all instrumentalities [625 
total for VIS] and 5 for expectancy).   
 The following were the PVI groups (each of which had four associated 
variables) that are addressed in the data tables to follow.  Using the example 
discussed previously these basic variables exist within each PVIG: 
• Selfimage_P  Probability (instrumentality). This was directly   
     reported. 
• Selfimage_V  Value to the individual. This was directly reported. 
• Selfimage_VIS Instrumentality x value (VIS).  This was calculated.   
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• Selfimage_Diff Value – instrumentality.  This was calculated.  
These were the PVI group names:    
1. Self image  
2. Employable  
3. Higher salary  
4. Professional opportunities 
5. Peer respect  
6. Career advancement  
7. Academic opportunities  
8. Downsizing protection  
9. Initial costs  
10. Credibility  
11. Professional respect (Colleagues)  
12. Annual salary increases 
13. Hiring influence  
14. Financial incentive to SEEK board certification  
15. Financial incentive to MAINTAIN board certification  
16. Non-professional co-workers’ respect  
17. Practice skills confidence  
18. Personal accomplishment  
19. Increased responsibility  
20. One time bonus  
21. Paid certification costs  
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22. Promotion potential  
23. Public notification   
24. Improved professional network  
25. Job requirement  
 Expectancy responses were re-coded into two variables due to apparent 
complexities with the question based on some respondent’s actions.  The first of these 
was AM_BC which had a binary classification of “Y” for yes if the respondent was 
currently board certified and an “N” if they were not.  The second variable was Exp 
(expectancy) for the numerical value (1 – 5) reported on the survey section on 
Question 26.  Despite problems with some persons understanding the question, only 
72 responses (3.4%) were lost due to inability to confirm the expectancy value. 
 
Instrumentality 
 Table 4-5 lists findings from the survey instrumentality questions in the order 
of the PVIG group listings on the ACI-P survey.  In general, the board certified 
pharmacists had a higher perception that rewards would occur than did the non-board 
certified pharmacists and 20 of 25 (80%) were different statistically at a significance 
level of p < 0.05.  The instrumentality differences were seen at the highest level for 
eight questions.  These all had statistically significant differences between means 
demonstrated by a t-score lower than negative 7.0 and a p of <0.0001.  These eight 
question response differences are listed in descending order based on t values:   
a. I would hire a board certified practitioner over another non-board   
 certified practitioner with otherwise equal qualifications. 
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Table 4-5.   Differences in Instrumentalities, (SD), between Board Certified (BCP)  
 and Non-Board Certified Pharmacists (NONBCP) 
 
Instrumentality Item 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus 
BCP 
difference 
t value 
p two-
tailed 
My self image will be improved 
by becoming board certified. 
3.43 
(1.25) 
4.02 
(0.92) 
-0.59 -9.74 <.0001* 
I would become more employable 
if I were board certified. 
3.07 
(1.13) 
3.7 
(0.93) 
-0.63 -11.16 <.0001* 
I will receive a higher annual 
salary if I am board certified. 
2.55 
(1.09) 
2.61 
(1.14) 
-0.06 -1.1 0.27 
My professional opportunities 
will improve with board 
certification. 
3.28 
(1.16) 
3.7 
(0.93) 
-0.42 -7.35 <.0001* 
I will have increased peer respect 
by becoming board certified. 
3.52 
(1.04) 
3.93 
(0.83) 
-0.41 -9.0 <.0001* 
My career will be positively 
advanced by becoming board 
certified. 
3.21 
(1.16) 
3.56 
(0.97) 
-0.35 -6.16 <.0001* 
My academic opportunities will 
improve if I am board certified. 
3.23 
(1.16) 
3.44 
(1.0) 
-0.21 -3.87 <.0001* 
In a workplace that is downsizing, 
board certification will protect my 
job. 
2.61 
(1.03) 
2.76 
(0.96) 
-0.15 -3.02 <.0001* 
My initial certification costs will 
be paid by my employer. 
2.38 
(1.32) 
2.92 
(1.68) 
-0.54 -7.47 <.0001* 
Board certification credentials 
will add credibility to my 
opinions. 
3.3 
(1.13) 
3.52 
(0.98) 
-0.22 -3.92 <.0001* 
Other practitioners within my 
profession will respect my board 
certification status. 
3.57 
(0.97) 
3.87 
(0.82) 
-0.3 -6.27 <.0001* 
If I am board certified I will 
receive higher annual salary 
increases. 
2.33 
(1.0) 
2.14 
(0.96) 
0.19 3.79 0.002* 
*=Statistically Significant 
 75 
Table 4-5.  Continued. 
 
Instrumentality Item 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus 
BCP 
difference 
t value 
p two-
tailed 
I would hire a board certified 
practitioner over another non-
board practitioner with otherwise 
equal qualifications. 
3.32 
(1.1) 
3.93 
(0.85) 
-0.61 -11.28 <.0001* 
Increased financial incentive from 
my employer would cause me to 
SEEK board certification status. 
3.54 
(1.18) 
3.65 
(1.14) 
-0.11 -1.98 0.049* 
Increased financial incentive from 
my employer would cause me to 
MAINTAIN board certification. 
3.8 
(1.09) 
3.84 
(1.17) 
-0.04 -0.67 0.50 
Non-professional co-workers will 
respect board certification status. 
2.64 
(1.08) 
2.7 
(0.99) 
-0.06 -1.09 0.27 
I will have increased confidence 
in my practice skills as a result of 
being board certified. 
3.43 
(1.23) 
3.59 
(1.08) 
-0.16 -2.58 0.01* 
I will feel a sense of personal 
accomplishment by becoming 
board certified. 
4.24 
(1.0) 
4.66 
(0.6) 
-0.42 -8.94 <.0001* 
I will have increased 
responsibility in my job role after 
becoming board certified. 
2.64 
(1.18) 
2.72 
(1.12) 
-0.08 -1.37 0.17 
I will receive a one time pay 
bonus upon completion of board 
certification. 
1.88 
(0.98) 
1.75 
(1.1) 
0.13 2.56 0.01* 
My recertification costs will be 
paid by my employer. 
2.12 
(1.09) 
2.32 
(1.43) 
-0.2 -3.22 0.001* 
I will be more likely to be 
promoted by my employer if I am 
board certified. 
2.57 
(1.09) 
2.68 
(1.08) 
-0.11 -1.91 0.056 
There would be a public 
notification of my achievement 
and status if I become board 
certified. 
2.72 
(1.14) 
2.2 
(1.31) 
-0.2 -3.35 0.001* 
I would have an improved 
professional network by 
becoming board certified. 
3.09 
(1.07) 
3.24 
(1.05) 
-0.15 -2.86 0.003* 
Board certification will become 
necessary for my job. 
2.42 
(1.07) 
2.83 
(1.18) 
-0.41 -7 <.0001* 
*=Statistically Significant 
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b. I would become more employable if I were board certified.  
c. My self image will be improved by becoming board certified.  
d. I will have increased peer respect by becoming board certified.  
e. I will feel a sense of personal accomplishment by becoming board certified. 
f. My initial certification costs will be paid by my employer. 
g. My professional opportunities will improve with board certification. 
h. Board certification will become necessary for my job. 
 For this particular group of comparative instrumentalities there was a more 
pronounced difference than in the others.  As noted, 20 of 25 (80%) of the 
instrumentality comparisons demonstrated statistically significant differences.  The 
group identified in the list above, however, may have more practical relevance since 
they have a much larger degree of difference. 
 In five of the questions the instrumentalities reported by the BCP’s were about 
the same as those listed by the NONBCP group due to no statistically significant 
differences.   
 This group is listed below (mean ranges in parentheses): 
i. Increased financial incentive from my employer would cause me to 
MAINTAIN board certification (Both about 3.8). 
j. I will receive a higher annual salary if I am board certified (Both about 2.6). 
k. Non-professional co-workers will respect my board certification status (Both 
about 2.7). 
l. I will have increased responsibility in my job after becoming board certified 
(Both about 2.7). 
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m. I will be more likely to be promoted by my employer if I am board certified 
(both about 2.6). 
 Four of these items had values for both groups below 3.0.  As a result, both 
groups perceived instrumentalities lower than the mid-point (3 on the 5 point scale).  
Although the responses were not very different statistically, the findings in the four 
below 3 were on the negative side of the scale.  In other words, despite that fact that 
they did not differ very much between groups, the overall perception of these 
instrumentalities was negative in both groups.     
 The question regarding an increased employer financial incentive to maintain 
board certification had a relatively high score from both groups indicating that this 
was an area of high perception of instrumentality.  
 Since all the responses captured on the instrumentality questions were able to 
be summed, the accumulated overall instrumentality was compared.  This is an 
important concept as the products of all instrumentality multiplied by the valences are 
accumulated and summed in the VIE equation.  The mean for the accumulated non-
board certified pharmacists (NONBCP) instrumentalities was 74.9 (95% CI 73.6 – 
76.5) compared to the mean for the board certified pharmacists (BCP) of 81.0 (95% 
CI 80.3 – 81.7) so overall this group scored at a neutral or near midpoint range.  The 
NONBCP and BCP groups were significantly different (t = -6.9, p < 0.0001).   
 A neutral accumulated instrumentality score would have been 75 (25 
questions x 3; on the 1-5 scale) and the highest attainable accumulated score would 
have been 125 (25 x 5; on the 1-5 scale).  Both groups were closer to the midpoint 
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than to the higher end and the NONBCP group was essentially neutral at 74.9 
compared to an actual midpoint of 75.         
 Similarly, taking a mean of the means for the instrumentalities shows the 
mean of all for the accumulated non-board certified pharmacists (NONBCP) 
instrumentalities at 3.0 (95% CI  2.93 – 3.06) compared to the instrumentality mean 
for the board certified pharmacists of 3.24 (95% CI 3.21 – 3.27).  These were 
significantly different (t = -6.9; p < 0.0001).     
 Even though the BCP group was just slightly higher than the NONBCP group, 
both groups were very near neutral, or near the midpoint, in their instrumentality.  
Their general impression that there would be a reward for effort put forth for board 
certification was nearly ambivalent.   
 In the VIE equation, scores calculated from the instrumentality questions 
would likely have had a neutral or negative pull on the calculations.   However, the 
values that were on the extremes of the instrumentality scores may have had a greater 
overall effect since they were not neutral.  The eleven statistically significant 
differences in means demonstrated that, in this large survey population, they were 
indeed different statistically but perhaps not to a degree that made them actually 
practically relevant.  Final determination of that position was examined by evaluating 
the differences in value and instrumentality (VI_Diff) and the products of the value 
and instrumentality scores (VIS).       
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Valence 
 Findings from the valence (value) questions and the differences between non-
board certified pharmacists and board certified pharmacists are displayed in Table 4-
6.  In general, 23 of 25 (92%) of board certified pharmacists had a higher perception 
of value (valence) than did the non-board certified pharmacists and these were 
significantly different.  The valence differences were seen at the highest level for four 
questions.  These all had practically and statistically significant differences between 
means demonstrated by a t-score lower than negative 7.0 and a p of <0.0001.     
 These four item responses are listed in descending order from the most 
difference noted:   
1. I value that my job will require board certification. 
2. I value board certification enough to positively influence a hiring decision. 
3. I value personal accomplishment demonstrated by a board certification. 
4. I value promotions based on board certification.  
 For this particular group of comparative valences there was a more 
pronounced difference than in the others.  As noted, 23 of 25 (92%) of the valence 
comparisons demonstrated statistically significant differences, but the group 
identified in the list above may have had more relevance since they had a much larger 
degree of difference. 
 In three of the questions, the valences reported by the BCP’s were about the 
same as those listed by the NONBCPs, i.e. they were not statistically different.  This 
group was, in order of descending from highest to lowest:
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Table 4-6.   Differences in Valences, (SD), between Board Certified (BCP) and Non- 
Board Certified Pharmacists (NONBCP) 
 
Valence Question/Statement 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
I value my self image. 
4.59 
(0.66) 
4.58 
(0.63) 
0.01 0.22 0.83 
I value becoming more 
employable. 
4.39 
(0.89) 
4.64 
(0.64) 
-0.25 -5.75 <.0001* 
I value a higher annual salary. 
4.32 
(0.85) 
4.44 
(0.77) 
-0.12 -2.9 0.004* 
I value professional opportunities. 
4.55 
(0.67) 
4.65 
(0.57) 
-0.1 -2.8 0.005* 
I value peer respect. 
4.22 
(0.84) 
4.39 
(0.74) 
-0.17 -3.96 <.0001* 
I value career advancement. 
4.36 
(0.83) 
4.51 
(0.68) 
-0.15 -3.42 0.0007* 
I value academic opportunities. 
3.7 
(1.13) 
3.8 
(1.03) 
-0.1 -3.87 0.0001* 
I value a protective effect from 
downsizing. 
4.1 
(0.99) 
4.26 
(0.92) 
-0.16 -3.02 0.0026* 
I value my initial certification 
costs being paid by my employer. 
3.94 
(1.22) 
4.07 
(1.1) 
-0.13 -2.38 0.0175* 
I value credentials to improve my 
credibility. 
3.99 
(0.99) 
4.13 
(0.93) 
-0.14 -3.07 0.0022* 
I value professional respect from 
my colleagues. 
4.27 
(0.79) 
4.39 
(0.69) 
-0.12 -3.01 0.0027* 
I value higher annual salary 
increases. 
4.28 
(0.86) 
4.37 
(0.79) 
-0.09 -2.05 0.0406* 
I value board certification enough 
to positively influence a hiring 
decision between candidates with 
otherwise equal qualifications. 
3.48 
(1.13) 
4.05 
(0.87) 
-0.57 -10.3 <.0001* 
I value a financial incentive from 
my employer based on SEEKING 
board certification. 
3.73 
(1.13) 
3.93 
(1.03) 
-0.2 -3.5 0.0005* 
*Statistically Significant 
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Table 4.6.  Continued. 
 
Valence Question/Statement 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
I value a financial incentive from 
my employer to MAINTAIN 
board certification status. 
3.93 
(1.04) 
4.14 
(0.96) 
-0.21 -4.19 <.0001* 
I value a non-professional co-
workers’ respect of board 
certification status. 
3.12 
(1.15) 
3.27 
(1.08) 
-0.15 -2.76 0.0058* 
I value increased confidence in 
my practice skills. 
4.42 
(0.79) 
4.47 
(0.69) 
-0.05 -1.26 0.2082 
I value personal accomplishment 
demonstrated by a board 
certification credential. 
4.19 
(1.02) 
4.55 
(0.72) 
-0.36 -7.31 <.0001* 
I value increased responsibility in 
my job role. 
3.75 
(0.99) 
3.85 
(0.91) 
-0.1 -1.98 0.0482* 
I value a one time pay bonus for 
completion of board certification. 
3.4 
(1.27) 
3.62 
(1.24) 
-0.22 -3.45 0.0006* 
I value that my employer would 
pay for my recertification costs. 
3.76 
(1.19) 
4.08 
(1.06) 
-0.32 -5.45 <.0001* 
I value promotions based on board 
certification. 
3.2 
(1.22) 
3.64 
(1.06) 
-0.44 -7.05 <.0001* 
I value a public notification of my 
achievement and status. 
2.84 
(1.24) 
3.05 
(1.18) 
-0.21 -3.48 0.0005* 
I value an improved professional 
network. 
3.87 
(1.01) 
3.93 
(0.9) 
-0.06 -1.33 0.1827 
I value that my job will require 
board certification. 
2.59 
(1.19) 
3.27 
(1.16) 
-0.68 -11.42 <.0001* 
*Statistically Significant 
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a. I value my self image. 
b. I value increased confidence in my practice skills. 
c. I value an improved professional network.  
 All three of these questions had responses above 3.8; placing values attributed 
to all three issues higher than the mid-point (3 on the 5 point scale).  Although these 
responses are not very different statistically, the findings in the three above 3.8 are on 
the positive side of the scale.  In other words, despite that fact that they don’t differ 
very much, the overall perceptions of these valences were positive in both groups. 
 Since all the responses captured on the valence items could be summed, the 
accumulated overall valence was compared.  As noted in the instrumentality section, 
this is an important concept as the products of all instrumentality multiplied by the 
valences are accumulated and summed in the VIE equation.  The mean of all for the 
accumulated non-board certified pharmacists (NONBCP) instrumentalities was 97.1 
(95% CI 95.8 to 98.4) compared to the mean for the board certified pharmacists 
(BCP) of 102.2 (95% CI 101 to 103). Overall, this group scored in the positive range 
although they were significantly different (t = -7.1, p < 0.0001). 
 A neutral accumulated valence score would have been 75 (25 questions x 3; 
on the 1-5 scale) and the highest attainable accumulated score would have been 125 
(25 x 5; on the 1-5 scale).  Both groups were on the higher end with the NONBCP 
group at 95.8 compared to 75 (higher than neutral,) and the BCP group was 102.2 
compared to 75 (higher than neutral).  
 Similarly, taking a mean of the means for the valences shows the mean of all 
for the accumulated non-board certified pharmacists (NONBCP) instrumentalities at 
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3.9 (95% CI of 3.8 to 3.95) compared to the valence mean for the board certified 
pharmacists (BCP) of 4.09 (95% CI of 4.06 to 4.11).  These were different and 
statistically significant.   
 The BCP group was slightly higher but both groups were on the positive side 
of the scale for valence, i.e. their general impression of values for these questions 
were relatively high.   
 In the VIE equation, scores calculated for the valence scores would have had a 
positive pull on the calculations, i.e. since they were above neutral they would have 
contributed more to the products since they were of a higher value.   Final 
determination of that position was examined by evaluating the differences in value 
and instrumentality (V_Diff) and the products of the value and instrumentality scores 
(VIS).   Extremes of differences on either end of the scales may have had a 
pronounced affect on overall variance on the factor model.  
 
Valence Minus Instrumentality (VI_Diff) 
 Valence is the same as value.  This comparison evaluates the valence or value 
item within a PVI group against the instrumentality item by subtracting the 
instrumentality from the valence.  During the literature search and design of the 
survey instrument (ACI-P) it was considered that the product of instrumentality and 
valence, as defined in the VIE equation, would produce useable results.   
Additionally, it was considered that if certain PVI groups showed larger differences 
than others it could be a beneficial addition to the evaluation of these PVIGs.  To 
accomplish this comparison each respondent’s instrumentality score was subtracted 
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from each valence score to achieve a difference score known as VI_Diff (V – I = 
VI_Diff).  This was done for each PVI group and the scores were summed.  The 
comparison of the instrumentality and valence tables demonstrated that this further 
evaluation was worth examining as the overall valence responses were higher than the 
instrumentality responses.   
 The point of examining the VI_Diff calculations was to look for extremes 
where board certified pharmacists may have had much higher values compared to 
instrumentalities and to evaluate areas where the inverse was true.  Table 4-7 lists the 
VI_Diff means, standard deviations, t-test values and the probability (two-tailed p) 
values for each.  The probability values indicate that 13 of 25 (52%) did not differ 
statistically.  Therefore the differences in valence and instrumentality were about the 
same for both groups.  Within this group, five of the PVI group overall responses had 
at least one mean value (in one of the VI_Diff measures) greater than 0.9, or nearly 
one full level of response higher for the valence than the instrumentality. These 
represented a higher level of perception  of values versus what may have been the 
reward (instrumentality). 
 The five PVI groups that were not significant, but interesting were: 
a. Paid recertification costs 
b. Higher salary 
c. Downsizing protection 
d. Increased responsibility 
e. Practice skills confidence 
 85 
Table 4-7.    Differences in Valences Minus Instrumentality Scores (V_Diff), (SD),  
 between Board Certified (BCP) and Non-Board Certified Pharmacists 
(NONBCP) 
 
PVI Groups (VI_Diff) 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
Self Image 
1.16 
(1.43) 
0.56 
(0.99) 
0.6 8.7 <.0001* 
Employable 
1.32 
(1.22) 
0.94 
(0.99) 
0.38 6.31 <.0001* 
Higher Salary 
1.77 
(1.34) 
1.83 
(1.3) 
-0.06 -0.8 0.42 
Professional Opportunities 
1.28 
(1.23) 
0.95 
(0.96) 
0.33 5.43 <.0001* 
Peer Respect 
0.71 
(1.13) 
0.46 
(0.87) 
0.25 4.45 <.0001* 
Career Advancement 
1.16 
(1.21) 
0.95 
(1.0) 
0.21 3.94 <.0001* 
Academic Opportunities 
0.47 
(1.5) 
0.37 
(1.17) 
0.1 1.36 0.17 
Downsizing Protection 
1.56 
(1.29) 
1.53 
(1.2) 
0.03 0.28 0.778 
Initial Costs 
1.55 
(1.63) 
1.15 
(1.69) 
0.4 4.72 <.0001* 
Credibility 
0.69 
(1.14) 
0.62 
(0.95) 
0.07 1.26 0.2066 
Professional Respect 
0.7 
(1.07) 
0.52 
(0.89) 
0.18 3.43 0.0006* 
Annual Salary Increase 
1.96 
(1.3) 
2.23 
(1.25) 
-0.27 -4.23 <.0001* 
Hiring Influence 
0.15 
(0.77) 
0.12 
(0.59) 
0.03 1.01 0.3143 
Financial Incentive to SEEK 
Board Certification 
0.2 
(1.06) 
0.28 
(0.93) 
-0.08 -1.56 0.1206 
*=Statistically Significant 
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Table 4-7.  Continued. 
PVI Groups (VI_Diff) 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
Financial Incentive to 
MAINTAIN Board Certification 
0.13 
(0.92) 
0.3 
(1.02) 
-0.17 -3.35 0.0008* 
Non-Professional Respect 
0.48 
(1.1) 
0.58 
(1.06) 
-0.1 -1.79 0.0735 
Practice Skills Confidence 
0.99 
(1.22) 
0.88 
(1.0) 
0.11 1.8 0.0725 
Personal Accomplishment 
-0.05 
(0.82) 
-0.11 
(0.52) 
0.06 1.59 0.1135 
Increased Responsibility 
1.11 
(1.3) 
1.13 
(1.16) 
-0.02 -0.24 0.8137 
One Time Bonus 
1.52 
(1.5) 
1.87 
(1.5) 
-0.35 -4.61 <.0001* 
Paid Recertification Costs 
1.64 
(1.46) 
1.77 
(1.53) 
-0.13 -1.68 0.0929 
Promotion Potential 
0.64 
(1.24) 
0.96 
(1.19) 
-0.32 -5.23 <.0001* 
Public Notification 
0.12 
(1.2) 
0.13 
(1.35) 
-0.01 -0.18 0.8579 
Improved Professional Network 
0.78 
(1.15) 
0.69 
(0.97) 
0.09 1.54 0.1246 
Job Requirement 
0.17 
(1.07) 
0.44 
(1.13) 
-0.27 -4.75 <.0001* 
*=Statistically Significant 
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There were also two extreme findings on the VI-Diff scale where there were 
statistically different groups.  These were where BCP responses were higher than   
NONBCP and where NONBCP responses were higher than BCP.  The BCP higher 
than NONBCP VI_Diff statistically significant end of the responses showed four PVI 
groups.  These, listed in order of greatest difference descending to lowest, were; 
a. Promotion potential 
b. Job requirement 
c. One time bonus 
d. Annual salary increase 
 All values were negative for this group. This means that the perceptions of 
value for the board certified pharmacists were higher compared to the non-board 
certified pharmacists.   
 On the other end of the scale for comparison within this group were the 
positive t-test values where the NONBCP scores were higher than the BCP.  The 
following seven PVI groups showed areas where the non-board certified pharmacists 
had a higher difference in valence minus instrumentality (VI_Diff) responses than did 
the board certified pharmacists.  These, listed in order of greatest t-test value 
difference descending to lowest, with difference in VI_Diff level noted in 
parentheses, are: 
a. Self image (0.6) 
b. Employability (0.38) 
c. Professional opportunities (0.33) 
d. Initial costs (0.4) 
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e. Peer respect (0.25) 
f.   Career advancement (0.21) 
g. Professional respect (0.18) 
 Of this group, five had at least a VI_Diff mean greater than 0.9 in at least one 
of the groups.  These were self image, employability, professional opportunities, 
initial costs, and career advancement.   
 The purpose of the VI_Diff evaluation was to further examine the differences 
seen on overall comparison of valences and instrumentalities in the preceding 
sections.      
 
Valence Times Instrumentality (VI_Score) 
 
 Using an Expectancy Valence (VIE) mathematical approach to development 
of a survey instrument had as a basis the position that the product of the 
instrumentalities and the valences (values) would be more representative of the actual 
propensity of motivational force than either of the independent item types or scales.  
Additionally, the accumulation of these products provided the opportunity to not have 
the selection of some factor on an extreme end of one of the scales of the findings 
overly influence interpretation.  Thus far, a focus of the discussion has been on the 
areas where one overall propensity was noted for instrumentality, valence or the 
difference between valence and instrumentality.  These are all worthwhile 
examinations and lend some credence to the argument for evaluating those sections of 
the PVI groupings.  However, the most important of the four different components of 
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the PVI groups, each of which consists of instrumentality, valence, VI_Diff and the 
product of the valence and instrumentality (VI_Score), was the latter.     
 The valence times instrumentality score (VI_Score) was derived by 
multiplying the PVI group valence by the instrumentality within that group.  Each of 
the 25 PVI groups has a VI_Score.  The advantage of using this variable for  
evaluation of components of motivational force, aside from the fact that it was the 
basis for the VIE mathematical model, was that it had the potential advantage of 
smoothing out extremes on either the valence or instrumentality scales and may be 
more representative of  a more realistic measure of perception.   
 An examination of Table 4-8 demonstrates that 22 of 25 of the VI scores were 
different statistically and only one of 25 had a higher VIS for NONBCP than for 
BCP.  The PVI group that showed a higher VIS mean for NONBCP was annual 
salary increase and it was statistically significant at p < 0.05.    
 Evaluation of the instrumentality and valence responses demonstrated some 
interesting findings on extreme ends of each scale and also showed an overall 
tendency to be near a neutral point (3 on the 5 point scale) of instrumentality.  
However, the overall valence scores, although statistically different from each other 
as far as NONBCP and BCP, were nearer a 4 on the 5 point scale.  The lower and 
higher means overall were used to establish some parameters for low and higher end 
VI Scores (VIS).  
 If we consider all the VIS means below a product of 9.0 (3 of 5 for 
instrumentality x 3 of 5 for valence) to be in negative range, and all means with 
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Table 4-8.   Differences in Valences Times Instrumentality Scores (VI_Score), (SD),  
 between Board Certified (BCP) and Non-Board Certified Pharmacists     
 (NONBCP) 
 
PVI Groups (VI_Score) 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
Self Image 
15.72 
(6.28) 
18.58 
(5.3) 
-2.86 -9.99 <.0001* 
Employable 
13.78 
(6.25) 
17.3 
(5.25) 
-3.52 -11.36 <.0001* 
Higher Salary 
11.09 
(5.49) 
11.72 
(5.78) 
-0.63 -2.13 0.033* 
Professional Opportunities 
15.08 
(6.09) 
17.3 
(5.18) 
-2.22 -7.43 <.0001* 
Peer Respect 
15.1 
(5.9) 
17.45 
(5.21) 
-2.35 -7.94 <.0001* 
Career Advancement 
14.28 
(6.34) 
16.24 
(5.53) 
-1.96 -6.19 <.0001* 
Academic Opportunities 
12.15 
(6.1) 
13.45 
(5.98) 
-1.3 -4.22 <.0001* 
Downsizing Protection 
11.1 
(5.5) 
12.05 
(5.2) 
-0.95 -3.53 0.0004* 
Initial Costs 
9.65 
(6.59) 
12.5 
(8.48) 
-2.85 -7.83 <.0001* 
Credibility 
13.63 
(6.57) 
15.01 
(6.05) 
-1.38 -4.34 <.0001* 
Professional Respect 
15.45 
(5.62) 
17.195 
(5.038) 
-1.745 -6.16 <.0001* 
Annual Salary Increase 
10 
(4.94) 
9.33 
(4.63) 
0.67 2.76 0.0058* 
Hiring Influence 
12.52 
(6.79) 
16.48 
(6.1) 
-3.96 -11.6 <.0001* 
Financial Incentive to SEEK 
Board Certification 
13.99 
(7.16) 
15.12 
(6.96) 
-1.13 -3.15 0.0017* 
VI_Score is the product of multiplying the valence score times the instrumentality 
score for each I group *=Statistically significant. 
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Table 4-8.  Continued 
 
PVI Groups (VI_Score) 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
Financial Incentive to 
MAINTAIN Board Certification 
15.65 
(6.97) 
16.5 
(7.07) 
-0.85 -2.44 0.0146* 
Non-Professional Respect 
8.86 
(5.75) 
9.35 
(5.47) 
-0.49 -1.7 0.0899 
Practice Skills Confidence 
15.49 
(6.73) 
16.37 
(6.14) 
-0.88 -2.69 0.0072* 
Personal Accomplishment 
18.45 
(6.93) 
21.54 
(5.03) 
-3.09 -9.18 <.0001* 
Increased Responsibility 
10.28 
(5.95) 
10.83 
(5.9) 
-0.55 -1.83 0.0689 
One Time Bonus 
6.55 
(4.49) 
6.58 
(5.26) 
-0.03 -0.1 0.9187 
Paid Recertification Costs 
8.2 
(5.33) 
9.88 
(7.22) 
-1.68 -5.55 <.0001* 
Promotion Potential 
8.84 
(5.84) 
10.2 
(5.74) 
-1.36 -4.57 <.0001* 
Public Notification 
8.38 
(5.97) 
9.55 
(6.52) 
-1.17 -3.56 0.004* 
Improved Professional Network 
12.36 
(5.99) 
13.21 
(5.95) 
-0.85 -2.78 0.0055* 
Job Requirement 
6.95 
(5.53) 
10 
(6.39) 
-3.05 -10.28 <.0001* 
VI_Score is the product of multiplying the valence score times the instrumentality 
score for each I group *=Statistically significant. 
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 product of 16.0 (4 of 5 for instrumentality and 4 of 5 for valence) to be in the positive 
range, as indicated by the valence scores, we can then examine more closely the two 
ends of the scale.  However, regardless of how the scale extremes occur with the VI 
scores, each of the contributory VIS products were accumulated and summed in the 
VIE methodology.  Therefore, even if many of the VIS products did not measure as 
being on the high or low end, they did accumulate to a summary score.  Consequently 
each had some additive contribution to the final result. 
 There were a total of 6 of 25 (24%) of the VI scores for PVI groups that had at 
least one mean (NONBCP or BCP) below 9.0 (i.e. negative). These were: 
a. Job requirement 
b. Paid certification costs  
c. Promotion potential  
d. Public notification  
e. Non-professional respect (p = 0.09, not significant) 
f.   One time bonus (p = 0.9, not significant) 
 Of these, only non-professional respect and one time bonus were not 
significantly different.   But all of these VI score means fell into the negative range.  
Within the VIE calculation they made a contribution to the sums of all the VI scores 
but their impact was less than those that were more positive, i.e. above a 9.0 product.   
There were 10 of 25 (40%) that had at least one VI score mean for either NONBCP or 
BCP above 16.0.   All 10 of those were different statistically.  These are, in 
descending order from highest difference of means to lowest difference (with 
NONBCP minus BCP differences noted in parentheses): 
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a. Hiring influence (-3.96) 
b. Employability (-3.52) 
c. Self image (-2.86) 
d. Personal accomplishment (-3.09) 
e. Peer respect (-2.35) 
f.    Professional opportunities (-2.2) 
g. Career advancement (-1.96) 
h. Professional respect [colleagues] (-1.75)    
i.   Practice skills confidence (-0.88) 
j.   Financial incentive to MAINTAIN board certification (-0.85) 
 The more negative a number for a difference the more the BCP VI score 
means were higher than the NONBCP VI score means.  These higher end composites, 
i.e. valence times instrumentality (VI scores), added more to the accumulated VIE 
equation.   
 An evaluation of the VI scores that may have had the most impact on the 
overall differences between NONBCP and BCP shows eight of 25 (32%) that had t-
test values lower than negative -0.7.  These are listed in decreasing order of impact, 
i.e. the most extreme difference as reflected by t-test value: 
a. Hiring influence  
b. Employability  
c. Job requirement 
d. Self image  
e. Personal accomplishment 
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f.    Peer respect  
g. Initial costs  
h. Professional opportunities  
 These values represent the most variance between all the VI score means.  It 
would be expected that after completion of the VIE calculation that this latter group 
would have contributed in a large way to the overall VIE motivational force 
determined. 
 Figure 4-1 shows a spatial diagram of where respective VI scores fell on the 
score range of 1 to 25.  Note that two midpoint responses of 3 for the instrumentality 
and 3 for the valence item would produce a product of 9.0 and this line is marked on 
the diagram. 
 
Force of Motivation 
 Instrumentality, valence, the differences between valence and instrumentality 
(VI_Diff) and the product of instrumentality and valence (VIS) are all contributing 
factors to the force of motivation.  Up to this point, certain contributory effects on the 
upper, middle and lower ends of the respective scales have been evaluated.  The 
ultimate goal of this study was to not only determine the differences between 
instrumentality and valence but to also compare the overall force of motivation 
between non-board certified pharmacists and those that are board certified.   To 
complete this goal the force of motivation was calculated by the VIE model using the 
ACI-P methodology.  
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VIS 
Score
NONBCP BCP
25
24.5
24
23.5
23
22.5
22
21.5 Personal Accomplishment
21
20.5
20
19.5
19
18.5 Personal Accomplishment Self Image
18
17.5 Employable, Professional Ops, Peer Respect
17 Professional Respect
16.5 Hiring Influence, Fin Maintain, Prac Skills Conf
16 Career Advancement
15.5
Self Image, Professional Respect, FIN Maintain, 
Prac Skills Conf
15 Prof Ops, Peer Respect Credibility, FIN Seek
14.5 Career Advancement
14 Employable, Credibility, FIN Seek 
13.5 Academic Ops
13 Improved Network
12.5 Hiring Influence, Improved Network Initial Costs
12 Academic Ops Downsizing Protection
11.5 Higher Salary
11 Higher Salary, Downsizing Protection Increased Responsibility
10.5 Increased Responsibility
10 Initial Costs, Annual Costs Paid Cert Costs, Promotion Pot, Job Requirement
9.5 Annual Costs, Non-Prof Resp
9 Non-Prof Resp, Promotion Pot Public Notice
8.5 Public Notice
8 Paid Cert Costs
7.5
7 Job Requirement
6.5 One Time Bonus One Time Bonus
6
5.5
5
4.5
4
3.5
3
2.5
2
1.5
1
 
Figure 4-1.   VIS Score Relative Values for Non-Board Certified and Board Certified  
Pharmacists from 2007 ACI-P Survey. VIS= Valence-times-
Instrumentality score, ACI-P = Advanced Certification Index for 
Pharmacists.  Midpoint is 9.0.  
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Table 4-9 examines the components needed to complete this final step of the 
calculation and to determine if there was a tipping point, i.e. a point where a 
prediction could be made as to whether a pharmacist was board certified or non-board 
certified.  If so, that knowledge and methodology may be used to determine if a 
qualified pharmacist would have proper motivational force to pursue board 
certification.  
 Expectancy, as defined earlier, refers to the expectation, or anticipated chance 
of success of an effort leading to successful performance.  In this case that would be 
the exertion of effort leading to achievement of the designation of board certified 
in a specialty by BPS.  In the VIE equation it has a pivotal role in that it can 
contribute enough negative or positive influence to change the overall VIE 
motivational force (MF) outcome.  For example: 
a. If the summed VIS is a total of 400, which would be a high score 
representing a response of 4 for an instrumentality and 4 for a response on 
valence and the multiplied to reach 16 and then those 16 scores were 
summed to make 25 x 16 = 400;  
b. and there were two expectancy scores of 2 and 5; 
c. the resultant products for the overall VIE calculation would be; 
d. 2 x 400 = 800 for the low end of the expectancy (Exp) and; 
e. 5 x 400 = 2000; 
 With the same high level of VIS, the resultant VIE (MF) score could be as 
much as 250% larger based on the expectancy contribution.  There were examples of 
this type of occurrence in the survey findings just as there were examples where a  
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Table 4-9.   Differences in Expectancy, Sums of VIS and Motivational Force as  
  Calculated by ACI-P, (SD), between Board Certified (BCP) and Non- 
  Board Certified Pharmacists (NONBCP) 
 
Measures of ACI-P Scoring 
Methodology 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
Expectancy 
4.05 
(0.95) 
4.4 
(0.66) 
-0.35 -9.16 <.0001* 
Sums of all Valence x 
Instrumentality Calculations 
303.54 
(101) 
343.82 
(83) 
-40.28 -8.03 <.0001* 
Motivational Force (MF) based 
on ACI-P 
1248.8 
(540) 
1521.0 
(457) 
-272.2 10.15 <.0001* 
Confidence Intervals (95%) of 
MF from ACI-P Score 
1201-1296 1499-1544    
*=Statistically Significant 
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lower level of VIS, e.g. a neutral score of 3 for instrumentality times a 3 for valence 
across the board yielded a VIS low sum score, e.g.  225, but the expectation of 
success (Exp = 5) was high and that yielded a relatively high VIE (MF) score, e.g. 
1125 (225 x 225 = 1125).  These are very simple examples to demonstrate the effects 
of the Exp (expectancy) component of the VIE calculation. The VIS scores were 
much more complicated than what was demonstrated here and, since they were an 
accumulated (summed) result of 25 separate VI scores, the variance within those 25 
separate PVI groups was considerable.  
 Table 4-9 depicts that there was a significant difference between the mean 
expectancy (Exp) for the NONBCP and the BCP.  The NONBCP mean was 4.05 and 
the BCP mean was 4.4.  The difference between these was -0.35.  The overall impact 
on the VIE, or motivational force (MF), calculations had a higher contribution by the 
board certified pharmacists than did the expectancy of the non-board certified 
pharmacists.  So, in addition to being statistically significant the difference in these 
two means had a material impact on the final calculated MF.  
 Table 4-9 also shows a significant difference between the summed VI scores.  
The NONBCP mean was 303.5 and the BCP mean was 344.  The difference between 
these was -40.3.  The overall impact on the VIE (MF) calculations had a higher 
contribution by the board certified pharmacists than did the VI score accumulations 
(sums) of the non-board certified pharmacists.  This shows that, in addition to being 
statistically significant, the difference in these two means had a material impact on 
the final calculated MF.  
 99 
 The final calculated motivational force (MF) via the VIE calculation yielded a 
mean of 1249 (95% CI 1201 – 1296) for NONBCP and a mean of 1521 (95% CI 
1499 – 1544).  These were different statistically at a p < 0.0001.  The difference 
between the means was -272 (95% CI -321 to -224).   
 There were significant differences in every measure of the VIE components 
throughout the data.  In addition, these were material to the final calculation and there 
was a clear separation of the 95% confidence intervals for the calculated MF for 
NONBCP and BCP.  Pharmacists scoring an ACI-P score on this survey between 
1201 and 1206 were 95% of the time NONBCP.  Pharmacists scoring an ACI-P score 
on this survey between 1499 and 1544 were 95% of the time BCP.  There was a 
tipping point at approximately 1500 where a pharmacist would be likely to be a board 
certified pharmacist.  At this point the ACI-P appears to be an accurate predictor of a 
pharmacist’s board certification status.  ACI-P scores are stratified by BCP and 
NONBCP and the scores are different between groups.   
 
Validity of Survey Instrument 
 Validity is a measure of the amount to which a survey instrument is actually 
measuring what it is intended to measure.  There are different types of validity. One 
type is called face validity.  This is the degree to which an instrument appears to 
measure a construct or what it is intended to measure.   Face and content validity for 
the ACI-P was established by using a Delphi panel in a pilot survey prior to the 
primary research.    
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 Construct validity is a measure of how well a survey instrument measures a 
pre-defined or hypothesized pattern predicted by a model, theory or an a priori 
assumption.  If the position of the research is to validate a structure, or constructs, 
then the comparison would be to determine if the predicted matched the actual and 
this would be performed by confirmatory factor analysis.  Table 4-10 demonstrates 
the findings from the data on the four proposed domains, or constructs, from the ACI-
P.  These were in fact established not to prove but as a basis for development of 
questions that had instrumentality and valence pairs within each of these domains.  
There were statistically significant differences in each of the four compared a priori 
domains. 
 These a priori domains were calculated by summing the instrumentality and 
valences products from each PVI group within the items that belonged to that domain.  
The relative values of each within the NONBCP or BCP groups were not pivotal and 
not very meaningful since they had different numbers of questions within that domain 
and therefore would have had different anticipated sum scores.  The differences 
between the NONBCP and BCP groups are meaningful because they do have the 
same number of questions within each domain. 
 All four of the proposed domains do demonstrate a considerable difference.  
Therefore, as components of the overall VI scores, the items within each of these 
contributed in the same general direction, i.e. with the NONBCP lower on every 
measure than the BCP. 
 An exploratory factor analysis (EFA) was performed on the data to determine 
measurement constructs.  The initial loading on the factors demonstrated a one factor  
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Table 4-10.  Differences in VIS for a priori Proposed Domains, (SD), between Board  
  Certified (BCP) and Non-Board Certified Pharmacists (NONBCP) 
 
VIS a priori Domains 
Non-Board 
Certified 
(SD) 
Board 
Certified 
(SD) 
NONBCP 
minus BCP 
difference 
t value 
p two-
tailed 
VIS – Professional 
66.85 
(23.6) 
74.5 
(20) 
-7.65 -6.53 <.0001* 
VIS – Personal 
71.67 
(25.3) 
81.05 
(20.9) 
-9.38 -7.47 <.0001* 
VIS – Career 
89.9 
(37.4) 
106.6 
(31.8) 
-16.7 -8.97 <.0001* 
VIS – Financial 
75.14 
(27.6) 
81.7 
(27.9) 
-6.56 -4.56 <.0001* 
*Statistically significant. 
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solution, which is not uncommon.  Rotating the PVI group elements using Varimax 
(orthogonal) rotation and evaluating the instrumentality, valence and VI scores 
demonstrated a possibility for a 2, 3 and 4 factor solution.  If, as is customary, 
Eigenvalues below 1.0 were dropped, meaning that no factor was accounting for more 
variance than any single variable, and any factor that contained less than two 
variables were dropped, the solutions were simplified to either a 2 or 3 factor 
solution. 
 Since the intent of this research was to determine the applicability of the VIE 
model, and the expectancy (Exp, E) component is the same for any individual 
respondent, it was decided to use the VIS variables for the factor analysis.  In all 
factor solutions there were four variables that factored together. These were all from 
the a priori domain called “Financial”.  The 3 factor solution from exploratory factor 
analysis was further examined with a parallel axis analysis and was simplified to a 2 
factor solution as the third factor’s Eigenvalue which was marginal did not meet 
criteria for inclusion.  Table 4-11 shows the two factor solution, the factor loadings on 
each factor, and suggests names for the factors. 
 The two factor solution had a financial and an “other” factor.  A two factor 
solution explained 45% of the variance which was reasonable considering that there 
were 25 variables.   
 It was expected that the explanatory abilities or “lines” between the proposed 
domains would not be clear.  One particular variable, or PVI group, higher salary, 
which was proposed as existing in the financial domain did not load with any of the  
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Table 4-11.  Two Factor Solution from Factor Analysis and Parallel Axis, Analysis 
from ACI-P Survey Findings 
 
PVI Group Variable 
Factor 1 
Loading  
(PCP) 
Factor 2 
Loading 
(FS) 
a priori 
domain 
Career Advancement 0.7669 0.2118 Career 
Professional Opportunities 0.7658 0.1477 Professional 
Peer Respect 0.7621 0.1152 Professional 
Respect of Clinical Colleagues 0.7406 0.1008 Professional 
Credibility 0.7125 0.2551 Personal 
Personal Accomplishment 0.7114 0.1446 Personal 
Employable 0.7010 0.1735 Career 
Increased Confidence in Skills 0.6643 0.1266 Personal 
Self Image 0.6500 0.0925 Personal 
Improved Professional Network 0.6479 0.1708 Professional 
Responsibility 0.6366 0.2512 Career 
Hire Board Certified Pharmacists 0.6327 0.1722 Career 
Academic Opportunities 0.6065 0.1597 Career 
Promotion Potential 0.5958 0.4219 Career 
Downsizing Protection 0.5809 0.2808 Career 
NON Prof Respect 0.5538 0.2993 Professional 
Note: PCP=Professional, Career and Personal, FS=Financial Support, ACI-
P=Advanced Certification Index for Pharmacists, PVI=Perceived Valence 
Instrumentality. 
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Table 4-11.  Continued. 
 
PVI Group Variable 
Factor 1 
Loading  
(PCP) 
Factor 2 
Loading 
(FS) 
a priori 
domain 
Necessary for Job 0.5155 0.2217 Career 
Public Notice of Completion 0.4679 0.1708 Personal 
Higher Salary 0.4539 0.3690 Financial 
Financial SEEK 0.1970 0.6717 Financial 
Financial MAINTAIN 0.2026 0.6592 Financial 
Recertification Costs Paid by Employer 0.0316 0.6328 Financial 
Initial Costs Paid 0.0422 0.5453 Financial 
One Time Bonus paid 0.2251 0.5236 Financial 
Annual Salary Increase 0.4153 0.4981 Financial 
Note: PCP=Professional, Career and Personal, FS=Financial Support, ACI-
P=Advanced Certification Index for Pharmacists, PVI=Perceived Valence 
Instrumentality. 
 105 
other financial factors and may have been regarded by pharmacists as a perception of 
work “worth” rather than a financial consideration.  It was close to being a split factor 
loading but did meet the criteria for inclusion since the factor loading was > 0.4.  The 
two factor solution fit the survey findings.   
 These two constructs and number of PVI group variables associated with them 
were: 
1. Professional, Career and Personal (PCP), 19 PVI groups 
2. Financial Support (FS), 6 PVI groups 
 In both of the final factors, PCP and FS, the same general pattern was seen, 
i.e. the relative comparison of cumulative VI scores shows that the NONBCP scores 
(means) was between 87-92% of the BCP.  The PCP has the greatest difference where 
NONBCP was 87% of BCP group.  The FS group was slightly closer with the 
NONBCP at 92% of the BCP group.  Table 4-12 lists differences between NONBCP 
and BCP for the two factors.    
 
Reliability of Survey Instrument 
 The ACI-P is a survey instrument created specifically for this research.  As 
such, it had not been evaluated for reliability.  Reliability is essentially the extent to 
which a survey will provide the same results with repeated measurements or would 
this same test given in the future produce reliable results. 
 A method of the measurement of reliability for a survey instrument is 
Cronbach’s alpha
83, 87, 88
.  There are three measures of reliability; they are stability, 
equivalence and consistency.  Cronbach’s coefficient alpha measures consistency.    
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Table 4-12.   PCP and FS Comparisons Derived with Parallel Axis Analysis from  
ACI-P Survey Findings, VI Scores (VIS) for Two Factor Solution (Sum 
of V * I per Domain)  
 
Construct / Factor 
NOT 
Board 
Certified 
Board 
Certified 
Difference t value 
p two-
tailed 
VIS – Professional, 
Career, Personal  
239.49 
(84.8) 
273.86 
(68.9) 
-34.37 -8.21 <.0001* 
VIS – Financial Support 
64.05 
(24.3) 
69.96 
(25.3) 
-5.91 -4.57 <.0001* 
PCP = Professional, Career, and Personal, FS=Financial Support, VI=Valence times 
instrumentality, VIS=Valence times instrumentality scores, *=statistically significant 
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This test is frequently the primary measure of estimating internal consistency with a 
test or survey instrument.
88
    
 The Cronbach’s alpha reliability coefficient was computed using SAS on the 
measures of the ACI-P that were directly reported and not computed.  These were the 
recorded responses for questions and were related to instrumentality and valence for 
the overall measures within each factor.  Cronbach’s alpha has not been confirmed to 
be accurate using two measures reported and then computed based on responses on a 
test or survey.  The responses on the valence and instrumentality questions were used 
to compute the valence x instrumentality score (VIS) which was used for the primary 
factor analysis.    
 The value of raw versus standardized alpha coefficients is, at times, a point of 
contention so both values are supplied in Table 4-13.  They were nearly the same to 
two decimal points in most of the alpha calculations.  No questions from either the 
instrumentality or valence sections had to be removed to increase alpha. 
 There was no posited level of Cronbach’s alpha that would be judged 
acceptable to establish reliability for this survey instrument.  For the purposes of this 
research and for this instrument the questions existing in PVI groups are the most 
important aspect because neither of the individual scales (instrumentality or valence) 
is used alone and they are in fact presented in pairs on the ACI-P. The combined 
instrumentality plus valence values in Table 4-9 are the most important.   
 Table 4-13 lists the Cronbach’s alpha for several measures.  The standardized 
alpha for all was above the established baseline of an alpha of 0.7, which is a 
commonly accepted conservative level.  Reliability coefficients of 0.5 are acceptable 
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Table 4-13. Reliability Calculated with Cronbach’s Alpha for ACI-P Survey  
 Instrument 
 
 
Alpha coefficient 
(Raw) 
Alpha coefficient 
(Standardized) 
All ACI-P Instrumentality Questions 0.94 0.94 
Valence Questions Only 0.90 0.91 
Instrumentality Questions Only 0.91 0.92 
Valence PLUS Instrumentality – PCP 0.94 0.94 
Valence PLUS Instrumentality – FS 0.79 0.81 
ACI-P = Advance Certification Index for Pharmacists, PCP=Professional, Career and 
Professional, FS= Financial Support, Alpha=Cronbach’s alpha reliability coefficient 
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in some areas of research.  The final alpha coefficient for each of the 2 factor 
solutions, listed by ACI-P domain constructs, and based on instrumentality PLUS 
valence questions and responses were: 
1. Professional, Career and Personal – 0.94 
2. Financial Support – 0.81 
 Additionally, the overall standardized Cronbach’s alpha for the questions 
related to the overall survey, instrumentality, and valence were: 
3. All PVI groups – 0.94 
4. Instrumentality – 0.91 
5. Valence – 0.90 
 The overall test items within the instrumentality and valence groups were 
found reliable.  The two factored constructs of professional, career and personal 
(PCP), and financial support (FS) were reliable via calculated internal consistency 
with the alpha reliability coefficient. 
 
Comparison of 2004 BPS Survey Findings and 2007 ACI-P Findings 
 Table 1-1 showed the responses listed in 2004 by board certified pharmacists 
as tangible and intangible benefits that BPS certification may bring to the pharmacist.    
The ACI-P survey included these same question concepts.  These were not directly 
asked but were the same as the PVI groups which contained an instrumentality and 
valence question.  The ACI-P VI Scores were used for comparison.   
 The differences in survey findings from the BPS 2004 survey and findings 
from the ACI-P survey in 2007 are listed in Table 4-14 and in Table 4-15 which is a 
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Table 4-14.  Items and Responses from Board Certified Pharmacists from 2007  
ACI-P Survey Reported and Matched to Categories from 2004 BPS 
Survey (N=1561) 
 
Survey Item VI Scores % of Maximum (25) 
Hiring Priority 16.48 66% 
(Employer) Pay Certification Costs 15.12 60% 
Salary Increase (Higher Salary Now) 11.72 47% 
Increased Responsibility 10.83 43% 
Promotion Potential (Priority from 
BPS) 
10.2 41% 
(Employer) Pay Recertification Costs 9.88 40% 
Financial Incentive to Maintain BC 9.88 40% 
Public Notice 9.55 38% 
Salary Increase (Annual) 9.33 37% 
One time Pay Bonus 6.58 26% 
No Recognition 0 0% 
Table 4-14 Note: There was no option for No Recognition in the 2007 ACI-P survey. 
Scoring was done on various aspects of recognition. ACI-P=Advanced Certification 
Index for Pharmacists. 
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Table 4-15.  Tangible and Intangible Benefits That BPS Certification May Bring To  
the Pharmacist as Reported in BPS Online Survey Results 2004 
(Redisplay of Table 1-1)
63, 64
 
 
Survey Item Number of Responses % of Responses 
Pay Certification Costs 686 34% 
No Recognition 618 31% 
Pay Recertification Costs 433 22% 
Public Notice 325 16% 
Hiring Priority 324 16% 
Salary Increase 302 15% 
Pay BPS Annual Fee 296 15% 
Increased Responsibility 224 11% 
Promotion Priority 137 7% 
One-time Pay Bonus 98 5% 
BPS = Board of Pharmaceutical Specialties 
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repeat of information seen in Table 1-1 but sorted in descending order to facilitate 
comparison. 
 Comparison of this data was problematic.  The top five findings in both 
groups were similar.  Table 4-16 shows a side by side comparison of relative 
sequence.   There were no easily discernible patterns observed by comparing these 
two as the 2004 BPS survey allowed multiple answers, as did the 2007 ACI-P survey, 
but with different question or item types.   
 
Comparison of Additional Comments from 2007 ACI-P Survey 
 
 At the conclusion of the fifty-one questions that covered instrumentality, 
valence and expectations for the ACI-P and the 16 questions related to pharmacist 
demographics was a single comment opportunity.  This final section was in the form 
of a statement and said simply, “Additional comments related to board certification in 
Pharmacy practice:” This was not addressed or referred to in the directions.  The 
purpose of this question was to allow users to offer their candid comments on board 
certification in Pharmacy. 
 Of the 2,057 total survey respondents, 324 (15.8%) offered additional 
comments.  These comments were in form of narrative and more than one subject was  
addressed or offered by many of the pharmacists resulting in a total of 620 comments 
recorded and these divided by the two groups into 228 responses from 115 
pharmacists (36.8% of responses and 35.5% of pharmacists) for the non-board 
certified pharmacists.  The board certified pharmacists responding recorded 392 
responses from 209 pharmacists (63% of responses and 64.5% of pharmacists).    
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Table 4-16.  Comparison of Relative Sequence of Findings from 2004 BPS Survey  
    and 2007 ACI-P Survey, Highest to Lowest Based on the 2004 BPS  
    Survey. 
 
Survey Item 
2004 BPS Responses 
(Descending Order)  
N=1995 
2007 ACI-P Responses 
(Sequence Number) 
N=1561 
Pay Certification Costs 1 2 
No Recognition 2 0 
Pay Recertification Costs 3 6 
Hiring Priority 4 1 
Public Notice 4 7 
Pay BPS Annual Fee 5 6 
Salary Increase 5 3 
Increased Responsibility 6 4 
Promotion Priority 7 5 
One-time Pay Bonus 8 9 
ACI-P=Advanced Certification Index for Pharmacists 
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A review and analysis of the data suggested that the responses fell into some general 
areas.  These are listed in Table 4-17.  These comments were thought to be a large or 
medium effect, because they were offered by the respondent and therefore did not 
have to depend on interpretation of a pre-defined scale, an amount to be statistically 
meaningful in each group would be 27 respondents and a total of 54 for a large effect 
or 65 respondents in each group for a total of 130 for a medium effect per Cohen’s 
d.
81
     
 It was determined that a “large effect” sample size was sufficient for this 
additional finding group and the number to be included within each group was 27 
respondents.  It was determined that the overall responses that were over 27 in either 
group were the most important.  This list included the items found in Table 4-18.    
 If a further reduction in the findings were focused on the items from Table 4-
18 that had 27 responses in both groups then the most important overall findings were 
those listed in Table 4-19.   Essentially, these three would be the ones that are the 
most important.  
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Table 4-17.   Comparison of Non-Board Certified (NONBCP) and Board Certified  
Pharmacists (BCP) Findings from Additional Comments and Questions 
(Responses=620, Respondents=324) 
 
Findings from Additional Comments 
NONBCP 
(N=228) 
BCP 
(N=392) 
Need more Specialization / Board Certification 
Process Has Not Kept Pace 
55% 34% 
Value Unrecognized / Academic Preparation is 
Sufficient 
50% 38% 
Costs too High / Not enough Return on 
Investment 
23% 27% 
Makes No Difference in my Practice 17% 8% 
Test Not Equal to Ability 13% 8% 
Commentary on Survey / Questions 13% 29% 
Don’t See Better Practice in Other BCPs 10% 1% 
Board Certification is the way to / Easiest way 
to get Additional Letters after Name 
9% 28% 
Method to Make Money / CE Needed for 
Retesting 
6% 10% 
Required 4% 1% 
Too Specialized / Not General Enough 1% 2% 
Too Much US Practice Focus 0% 1% 
BCP = Board Certification in Pharmacy practice, CE=Continuing Education.  
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Table 4-18.  General Findings from Additional Comments; Responses Greater than  
   27 per Item in either NONBCP or BCP group (N = 591) 
CE = Continuing Education 
 
Findings from Additional Comments 
Number of 
Responses 
Percent of 
Responses 
Need More Specialization / 
Board Certification Process Has Not Kept Pace 
135 41.7% 
Value Unrecognized/Academic Preparation is Sufficient 135 41.7% 
Costs Too High/ Not Enough Return on Investment 83 25.6% 
Commentary on Survey/Questions 76 23.5% 
Board Certification is The Way to Go/ 
Easiest way to get Additional Letters after Name 
68 21.0% 
Makes No Difference in My Practice 35 10.8% 
Test Not Equal to Ability 31 9.6% 
Method to Make Money/CE Needed for Retesting 28 8.6% 
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Table 4-19.  General Findings from Additional Comments: Responses Greater than  
27 in NONBCP and BCP groups (N=353) 
 
Findings from Additional Comments 
Number of 
Responses 
Percent of 
Responses 
Need More Specialization / BC Has Not Kept 
Pace 
135 41.7% 
Value Unrecognized / Academic Prep OK 135 41.7% 
Costs Too High / Not Enough ROI 83 25.6% 
BC = Board certification in Pharmacy practice, ROI = Return on investment.
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Chapter 5. Study Discussion and Conclusions 
 
"All human actions have one or more of these seven causes:  chance, nature, 
compulsion, habit, reason, passion, desire." 
 
--Aristotle 
 
 
Discussion 
 The passions, interests and/or influences that cause people to take action have 
been the subjects of study through the ages.  The study of motivation has seen 
pioneers, many of whom were reviewed earlier, make attempts to either explain or 
quantify these influences.   Categorization and a qualitative approach is a convenient 
way to attempt to summarize or encapsulate these influences.  Quantification of these 
influences, i.e. motivational forces, has been somewhat more elusive. This study has 
posited that the Expectancy Valence (VIE) model could be applied to equivalently 
qualified pharmacists that were eligible to pursue specialty certification in Pharmacy 
practice known as board certification, via the Board of Pharmaceutical Specialties, to 
determine why some would choose this path and others would not.  This was found to 
be true in that the motivational force calculated by the Advanced Certification Index 
for Pharmacists (ACI-P) showed a significant difference between the two groups. 
 The realms of medication management and clinical Pharmacy practice 
continue to get more and more complicated.  The impact of pharmacists on  
the economic, clinical, and humanistic outcomes of patients has been increasing.  
With the current, and anticipated escalating, level of new drugs and treatment 
modalities, as well as biotechnology drugs, the need for advanced knowledge levels 
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for these new advents is considerable.  Some would argue that the role of formal 
traditional Pharmacy education is to prepare pharmacists for that knowledge level.  
Pharmacy continuing education would then continue the process of assuring that 
pharmacists stay current.   
 But that presupposes that the education received, as well as training in the 
customary curricula, covers all the specifics of any particular practice area within the 
profession.  Some would argue that the difficulty in achieving this level of specific 
training in itself supports specialization.  Board Certification on the other hand is 
designed to define the parameters by which a pharmacist could be validated as a 
specialty practitioner.  Differences in opinion of the needs to be a pharmacy 
practitioner exist and some of the fundamental issues revolve around the types of 
education, training, residencies, certifications and degrees one must hold to be 
classified as an expert in a particular field of practice. 
 
Additional Comments Analysis 
  The additional comments section at the end of the ACI-P survey had a fair 
response rate (N=324, 15.8% of all respondents).  A considerable number of 
pharmacists in this survey who were asked to offer their opinions of board 
certification in general felt that the board certification process is either excessive or 
that specialization is not specialized enough and therefore does not meet their needs.  
These were diametrically opposed opinions. Pharmacists responding to this 
commentary based survey question, as listed in Table 5-1, reported that about 42%  
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Table 5-1.   Summarized Findings from Additional Comments with Combined  
 Groups (N=461) 
 
Findings from Additional Comments 
Number of 
Responses 
Percentage of 
Responses 
Need More Specialization / BC Has Not Kept 
Pace 
135 41.7% 
Value recognized / Academic Prep OK 135 41.7% 
Financial Perceptions 111 34.3% 
Not Proven in Practice 80 24.7% 
BC = Board Certified in Pharmacy practice 
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(135 of 324) of the time there was a need for more specialization and that perhaps the 
process of board certification in Pharmacy had not kept pace with their needs.  Others 
reported at the same rate, 42% (135 of 324), that the value was unrecognized for 
board certification and that academic preparation was adequate.  Another important 
result from these narrative responses was that about 26% (83 of 324) of the 
respondents found the costs for board certification to be too high or that the costs did 
not return enough on investment.  These three areas are important focal points for any 
future messages developed to convey the importance and need for board certification.  
Some findings from the comments entries that did not make inclusion, since these 
were categorized differently, would be important if they were combined as “not 
proven in practice”.  These would be “makes no difference in my practice”, “test not 
equal to ability” and “don’t see better practice in other BCPs”.  With this new 
combined group the percentage of overall pharmacists falling into this “not proven in 
practice” would be 24.7% (35 + 32 + 13/ 324).  This may be important to the process 
of board certification since this sentiment was a more exaggerated finding in the non-
board certified pharmacist group (Table 4.13).  An additional combination group 
could be the “financial perceptions”. These would include “costs too high/not enough 
ROI” and “method to make money/CE needed to for recertification”.  As a combined 
variable of financial perceptions this group, which just fell under the 27 cut point on 
one of the four previously included groups, would represent 34% (111 of 324) of 
findings.  A summary of the findings from these responses is listed in Table 5-1. 
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Instrumentality 
 Instrumentality differences were noted between the non-board certified 
pharmacists and the board certified pharmacists.  Instrumentality is a perceived or 
known probability that a performance will lead to an outcome.  It is also called a  
performance-to-outcome expectancy (P ? O).  The board certified pharmacists had a 
higher instrumentality on 20 of 25 (80%) of the instrumentality measures in the 
survey and these were statistically significant.   
 The responses to these eight questions were the most pronounced:     
a. I would hire a board certified practitioner over another non-board certified 
practitioner with otherwise equal qualifications. 
b. I would become more employable if I were board certified.  
c. My self image will be improved by becoming board certified.  
d. I will have increased peer respect by becoming board certified. 
e. I will feel a sense of personal accomplishment by becoming board 
certified. 
f.    My initial certification costs will be paid by my employer. 
g. My professional opportunities will improve with board certification. 
h. Board certification will become necessary for my job. 
 If this research was based on the instrumentality scale alone these items would 
be the points of most interest.  They would also perhaps offer a window on areas to 
improve the perception of board certification.  The most interesting finding in this 
comparison may be that despite statistically significant differences in the two groups 
the overall accumulated instrumentality scores was near the neutral score for both 
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groups.   This means that the perceived likelihood of reward of each of the PVI 
groups was nearly neutral. 
 There was also a group that was about the same.  The items and responses in 
this group were: 
a. Increased financial incentive from my employer would cause me to 
MAINTAIN board certification (Both about 3.8). 
b. I will receive a higher annual salary if I am board certified (both about 
2.6).  
c. Non-professional co-workers will respect my board certification status 
(both about 2.7). 
d. I will have increased responsibility in my job after becoming board 
certified (both about 2.7) 
e. I will be more likely to be promoted by my employer if I am board 
certified (both about 2.6) 
  Only one of the members of this grouping was not different statistically and 
was positive (3.8).  That one however is quite telling.  Financial incentive from an 
employer seems important to both the non-board certified and board certified 
pharmacists to an equivalent degree.  This is an important finding and may be the 
basis for an important communication regarding board certification.  The other four 
of the non-different group were about the same for the BCP and NONBCP groups, 
however they were all on the negative side (< 3.0).  If these issues are to be 
considered important to the profession and to the status of board certification, they 
will need to be addressed as they are obviously not considered likely to occur.   
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Valence 
   Valence differences were more pronounced than those seen with the 
instrumentality items.  Instrumentality may be something outside of the control of the 
pharmacist.  It is in essence a measure of the current environment in which they work, 
live, and operate.  Perhaps responses on these items were a pragmatic statement of 
their reality.  It was not surprising that the instrumentality scores were relatively 
neutral, with some exceptions, since these findings may be a true measure of 
pharmacist’s thoughts on rewards associated with board certification.  These 
perceptions of low reward may be linked to the large numbers of pharmacists that 
have not sought board certification. 
 In general the valence scores were higher than the instrumentality scores.  
There were 23 of 25 that were statistically different between the non-board certified 
pharmacists and those that were board certified.  The valence differences were seen at 
the highest level for four items.  These were, in descending order of the most 
difference noted:   
a. I value that my job will require board certification. 
b. I value board certification enough to positively influence a hiring decision. 
c. I value personal accomplishment demonstrated by a board certification. 
d. I value promotions based on board certification.  
 For this particular group of comparative valences there was a more 
pronounced difference than in the others.  These are definitely areas where either 
addressing the extreme differences in non-board certified pharmacist’s perceived 
value would be indicated or where actions should be taken to achieve work place 
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acceptance and reward for board certification.  Alternatively, it may indicate that 
board certification does not have a place and is not valued by many pharmacists. 
 In three of the questions, the valences reported by the BCP’s were about the 
same as those listed by the NONBCP group and were not statistically different.   This 
group was: 
a. I value my self image. 
b. I value increased confidence in my practice skills. 
c. I value an improved professional network.  
 All three of these questions had responses above 3.8 so values attributed to all 
three issues were higher than the mid-point (3 on the 5 point scale).  Although these 
responses are not very different statistically, the findings in the three above 3.8 are on 
the positive side of the scale.  In other words, despite the fact that they don’t differ 
greatly, the overall perception of these valences, in both groups, was positive 
indicating a potential opportunity area for perfecting communication and a clear 
message regarding the value of board certification to pharmacists and to some extent 
employers.     
 All of the responses captured on the valence items were summed.   Both 
groups were on the higher end with the NONBCP group at 95.8 versus 75 (higher 
than neutral) and the BCP group at 102.2 versus 75 (higher than neutral).       
 Similarly, taking a mean of the means for the valences shows that the BCP 
group is slightly higher but both groups are on the positive side of the scale for 
valence, i.e. their general impression of values for these items was high.   
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 In the VIE equation, scores calculated for the valence scores had a positive 
influence, i.e. > 3.0, effect on the calculations.   
 
Valence Times Instrumentality (VI_Score) 
 Two breakpoints were established for the low and high end means of the VI 
scores (VIS).  These were a product of < 9.0 for the negative range and product of 
16.0 for valence in the high positive range.  Regardless of how the scale extremes 
occur with the VIS each of the contributory VIS products are accumulated and 
summed in the VIE methodology.  Therefore, even if many of the VIS products did 
not measure as being on the high or low end, they did accumulate to a summary score 
and each had some additive contribution to the summary score. 
 There were a total of 6 of 25 (24%) of the VI scores for PVI groups that had at 
least one mean (NONBCP or BCP) below 9.0. These were: 
a. Job requirement  
b. Paid certification costs  
c. Promotion potential  
d. Public notification  
e. Non-professional respect (p = 0.09, not significant) 
f.    One time bonus (p = 0.9, not significant) 
 Of these, only non-professional respect and one-time bonus were not 
statistically different.   All of these VI score means fell into the negative range.  
Within the VIE calculation they made a contribution to the sums of all the VI scores 
but their impact was less than those that are more positive, i.e. above a 9.0 product.   
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 There were 10 of 25 (40%) that had at least one VI score mean for either 
NONBCP or BCP above 16.0.   All 10 of those were different statistically between 
the non-board and board certified pharmacists. These were, in descending order from 
highest difference of means to lowest difference (with NONBCP minus BCP 
differences in means noted in parentheses): 
a. Hiring influence (-3.96) 
b. Employability (-3.52) 
c. Self image (-2.86) 
d. Personal accomplishment (-3.09) 
e. Peer respect (-2.35) 
f.    Professional opportunities (-2.2) 
g. Career advancement (-1.96) 
h. Professional respect [colleagues] (-1.75)  
i.  Practice skills confidence (-0.88) 
j.    Financial incentive to MAINTAIN board certification (-0.85) 
 The more negative a number for a difference the more the BCP VI score 
means were higher than the NONBCP VI score means.   This higher end composite, 
i.e. valence times instrumentality (VI) scores added more to the accumulated VIE 
calculation. 
 An evaluation of the VI scores showed that 8 of 25 (32%) had the most impact 
on the overall differences between NONBCP and BCP.   These are listed in 
decreasing order of impact, i.e. the most extreme difference as indicated by t value to 
the lowest level within the group. 
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a. Hiring influence  
b. Employability  
c. Job requirement  
d. Self image 
e. Personal accomplishment 
f.    Peer respect  
g. Initial costs  
h. Professional opportunities  
 These values represent the most variance between all the VI score means.  
This group contributed more to the completion of the VIE calculation and to the 
resultant calculation of motivational force. 
 
Valence Minus Instrumentality (VI_Diff) 
 The valence-minus-instrumentality scores were covered in detail in Chapter 
IV.  This was a computation to determine the extremes of the differences in the two 
scales.  There were 13 of 25 (52%) that did not differ statistically.  Therefore the 
differences in valence and instrumentality were about the same for both groups.  
Within this group, five of the PVI group overall responses had at least one mean 
value greater than 0.9, or nearly one full level of response higher for the valence than 
the instrumentality.  These represented a higher level of perception of value than for 
instrumentality (reward).  
 The five PVI groups falling into this group listed by PVI group name were: 
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a. Paid recertification costs 
b. Higher salary 
c. Downsizing protection 
d. Increased responsibility 
e. Practice skills confidence 
 There were also two extreme findings on the VI_Diff scale where there were 
statistically different groups; these were where BCP responses were higher than 
NONBCP and where NONBCP responses were higher than BCP. 
 The BCP higher than NONBCP VI_Diff statistically significant end of the 
responses showed four PVI groups.  These, listed in order of greatest difference 
descending to lowest, were: 
f.    Promotion potential 
g. Job requirement 
h. One time bonus 
i.    Annual salary increase 
 All values were negative for this group, which means that the perceptions of 
value for the board certified pharmacists were higher compared to the non-board 
certified pharmacists.  Three of these, promotion potential, one time bonus and annual 
salary increase, had at least one mean value of 0.9 or greater representing almost a 
full level higher (on the 1-5 scale) for the valence than for the instrumentality.   
 On the other end of the scale for comparison of this group were the positive 
values where the non-board certified pharmacists’ perceptions of value were higher 
than the board certified pharmacists.  The following PVI groups showed areas where 
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the non-board certified pharmacists had a higher difference in valence-minus-
instrumentality responses than did the board certified pharmacists.   
a. Self image (0.6) 
b. Employability (0.38) 
c. Professional opportunities (0.33) 
d. Initial costs (0.4) 
e. Peer respect (0.25) 
f.    Career advancement (0.21) 
g. Professional respect (0.18) 
 Of this group, five had at least a one VI_Diff mean in one of the groups 
greater than 0.9.  These were self image, employability, professional opportunities, 
initial costs, and career advancement.  In all of these, particularly the five with the 
highest differences, there may be an opportunity to close the gap between perceived 
value and instrumentality.  A focus here would be to improve the likelihood that some 
of the things that the non-board certified pharmacists held in high value but that they 
felt would not come to pass would actually be realized.   This area may represent an 
opportunity to refine the message of board certification to employers and emphasize 
the importance and value of a board certification.  
 The purpose of the VI_Diff evaluation was to further examine the differences 
seen on overall comparison of valences and instrumentalities in the preceding 
sections.  The VI differences were not used in the computation of any values for the 
final motivational force.   
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Motivational Force Computations 
 A methodology to calculate and compare motivational force between groups 
was a primary endpoint of this research.  Instrumentality, valence and the product of 
instrumentality and valence were all contributing factors to the force of motivation 
within the VIE model.  Expectancy, as defined earlier, refers to the expectation, or 
anticipated chance of success of an effort leading to successful performance.  In this 
case that would be exertion of effort leading to achievement of the designation of 
board certification in a specialty by BPS.  In the VIE equation it has a pivotal role in 
that it can contribute enough negative or positive influence to change the overall VIE 
(motivational force [MF]) outcome.  There was a statistically significant difference 
between the mean expectancy (Exp) for NONBCP and BCP.  The NONBCP mean 
was 4.05 and the BCP mean was 4.4.  The difference between these was -0.35.  The 
overall impact on the VIE, or motivational force (MF), calculations was a higher 
contribution by the board certified pharmacists than was the expectancy of the non-
board certified pharmacists.  In addition to being statistically significant the 
difference in these two means had a material impact on the final calculated MF.  
 The final calculated motivational force (MF) via the VIE calculation yielded a 
mean of 1249 (95% CI 1201 – 1296) for NONBCP and a mean of 1521 (95% CI 
1499 – 1544).  These were statistically and materially different.  The difference 
between the means was -272 (95% CI -321 to -224) indicating a large separation 
between the two groups (22% of the NONBCP mean and 18% of the BCP mean).   
 Pharmacists scoring an ACI-P score in this data between 1201 and 1206 were 
95% of the time NONBCP.  Pharmacists scoring an ACI-P score on this survey 
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between 1499 and 1544 were 95% of the time BCP.  There was a tipping point at 
approximately 1500 (1500 - 1520) where a pharmacist would be found to be board 
certified in Pharmacy practice 95% of the time.   
 
Validity and Reliability of ACI-P 
 The Advanced Certification Index for Pharmacists (ACI-P) proved to be a 
valid and reliable tool.  Validation of constructs demonstrated that there were two 
factors, or domains, rather than the four proposed. These were: 
1. Professional, Career and Personal 
2. Financial Support 
 Construct validity was established with these two factors.  Face and content 
validity was established by a pilot survey.  Reliability was confirmed for the two 
factors using Cronbach’s alpha with alpha reliability coefficient values of 0.94 for the 
professional, career and personal (PCP) construct and 0.81 for financial support (FS).  
Additionally, the overall ACI-P had an alpha coefficient of 0.94, the instrumentality 
scale had an alpha of 0.91 and the valence scale had an alpha of 0.9.   All of these 
were equal to or above the criterion established of 0.7 and therefore demonstrate 
internal consistency of the test items.    
 There were material differences in certain areas of instrumentality, expectancy 
and VI scores.  Expectancy of successful completion of the board certification 
process weighed heavily in establishing motivational force.  The two factors 
(domains) found in the structure of the ACI-P were professional, career and personal 
(PCP), and financial support (FS).  These were different than the a priori proposed 
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domains but still include the initial classifications, only they are combined rather than 
in existence separately as originally proposed.  The standardized alpha for all was 
above the established conservative baseline of alpha of 0.7 which is a commonly 
accepted level, although minimum levels as low as 0.5 are accepted by some.
83,84
  The 
final alpha for each of the 2 factor solutions, listed by ACI-P domain constructs, and 
based on instrumentality PLUS valence questions and responses were: 
1. Professional, Career and Personal – 0.94 
2. Financial Support – 0.81 
The overall Cronbach’s alpha reliability coefficient for the ACI-P was 0.94.   
 
Tipping Point Confirmed 
 A tipping point of a score of 1500 on the ACI-P exists.   Pharmacists scoring 
between 1499 and 1544 on the ACI-P are 95% of the time board certified 
pharmacists.  The ACI-P was not intended as a predictive indicator but the data 
suggests that given at the appropriate point in a pharmacist’s career it could indicate 
whether they will or will not pursue board certification.  Since that “career point” 
may move or change based on external endpoints or by changes in the acceptance of 
board certification’s importance or value, a point in time score for a pharmacist would 
not be expected to be accurate for any length of time.  The length of time of accuracy 
for scores and findings from the ACI-P is a point for future research. 
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Limitations of the Study 
1. There was no way to control duplicate entries by pharmacists as the survey 
instrument was internet based and did not limit one user to one entry. 
2. There was no way to prevent non-pharmacists from completing the survey. 
3. It could be argued that non-board certified pharmacists have no specialty area 
of practice and therefore may have a different point of  reference than those 
that are board certified in a specialty. 
4. There are no totals of board certified and non-board certified pharmacists that 
received notification of the survey and therefore no response rate could be 
calculated. 
5. Access to the internet could have provided information on what was not truly 
a cross section of the pharmacist population. 
6. Members of the participating pharmacy organizations may not have been truly 
representative of the pharmacist population in the United States. 
 
Conclusions 
 This research was enhanced by the cooperation, support and participation by 
four major Pharmacy organizations and the Board of Pharmaceutical Specialties.  No 
surveys of this magnitude including this many Pharmacy organizations were found in 
the literature.  The cooperative nature and high interest given this project by these 
different, and sometimes disparate organizations, demonstrates that there is high 
interest in this particular area.   
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 If board certification is to move into a leadership role for advancing the 
practice of Pharmacy and establishing the standards from which it originated, there 
are 12 points that must be addressed.  The separate recommendations listed below are 
based on approximately five years of study on this issue, research findings from this 
study on the numerical scales, free text commentary captured for 16% of the 
respondents, voluntary offers of opinions from thought leaders during this research 
and 27 years of work place experience. 
 
Recommendations for the Future of Board Certification in Pharmacy 
• Recommendation 1.  Employer recognition of the value of board certification 
in Pharmacy practice must be improved.   
• Recommendation 2.  Tangible and intangible rewards for pharmacists 
achieving board certification must be identified and improved. 
• Recommendation 3.  The significant differences between board certified and 
non-board certified pharmacists as far as perceptions of value must be 
addressed via promotion, communication and/or engagement of non-board 
certified pharmacists. 
• Recommendation 4.  The essentially neutral perception of rewards by both 
board certified and non-board certified pharmacists must be addressed via 
promotion, communication and/or engagement by other means.    
• Recommendation 5.  The relatively high range of perceptions of value for both 
board certified and non-board certified pharmacists form a strength and should 
be used as a basis for fashioning a positive promotional message.  
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• Recommendation 6.  Financial aspects related to board certification must be 
addressed.  These include perceptions in general of costs to reward or return 
on investment.  Solutions should be sought for shifting the costs from the 
individual practitioner. 
• Recommendation 7.  Proof of superiority of practice skills and/or improved 
patient outcomes by board certified practitioners is a fundamental need and 
must be proven. 
• Recommendation 8.  Evaluations of current applicability of board certification 
categories and recommendations for future needs must be undertaken.   
• Recommendation 9.  Some consideration should be given to bringing 
pharmacists that have been practicing for many years into the fold of board 
certification.  Peer evaluation along with specified didactic material 
completion seems reasonable. A non-test mechanism for this effort should be 
evaluated. 
• Recommendation 10.  All Pharmacy organizations must financially support 
and endorse board certification in Pharmacy practice for this credentialing to 
have a growing future.  A one time endowment of monies may be needed to 
establish a higher base number of board certified pharmacists.  
• Recommendation 11.  The Advanced Certification Index for Pharmacists 
(ACI-P) should be used as a tracking mechanism to see how actions taken 
with regard to board certification affect the motivational force over time of 
qualified pharmacists to seek board certification in Pharmacy practice. 
Temptation to simplify the tool should be avoided as the specifics of the 
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survey instrument tool may help simultaneously and specifically track minor 
changes on several scales.  
• Recommendation 12.  Additional efforts by BPS to ensure that its processes 
remain current and credible, and to educate the profession and the public 
about Board Certification in Pharmacy, will be resource-intensive.  In order 
for BPS to be successful and accomplish these goals, sufficient resources, 
both financial and personnel, must be made available. 
 In this study, the investigator has developed an important survey instrument 
for the study of motivational force with pharmacists and has made findings that are 
both interesting and important to the profession of Pharmacy and to the future of 
Pharmacy practice.    
 
Contributions of this Research 
 Considerable contributions of this research included, but were not limited to, 
the following: 
• A survey instrument, the ACI-P, was developed based on a mathematical 
model of motivation.  This tool allows a quantification of motivational force 
and motivating factors. 
• The survey instrument was validated and the constructs of the validation were 
found to be reliable.  
• A survey that included cooperation of APhA, ASHP, ACCP and AACP as 
well as the Board of Pharmaceutical Specialties was deployed.  This 
cooperative participation indicated a high level of interest and perhaps a 
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willingness to pursue a joint approach to the issues related to board 
certification in Pharmacy practice. 
• The survey instrument was deployed and all data retrieval was done using an 
internet-based electronic communication and data collection methods.  A good 
response to the survey was achieved. 
• Statistically significant differences in board certified and non-board 
pharmacists were found for most measures of instrumentality.  Information 
was gleaned from this data that suggested changes in message and perhaps 
direction for the profession of Pharmacy.  
• Statistically significant differences in board certified and non-board 
pharmacists were found for most measures of valence.  Information was 
gleaned from this data that suggested changes in message and perhaps 
direction for the profession of Pharmacy.  
• Statistically significant differences in board certified and non-board 
pharmacists were found for most measures of valence-times-instrumentality 
(VIS).  Information was gleaned from this data that suggested changes in 
message and perhaps direction for the profession of Pharmacy.  
• Statistically significant differences in board certified and non-board 
pharmacists were found for the calculated motivational force (MF).  
Information was gleaned from this data that suggested changes in message 
and perhaps direction for the profession of Pharmacy.  
• Narrative based commentary offered by 324 pharmacists produced 620 
meaningful findings that were classified and stratified into useable groups and 
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further enhanced the findings of the mathematical scales of the ACI-P.  The 
narrative component should be retained as a part of the survey instrument.   
 The findings in this research present opportunities as well as challenges for 
Pharmacy practitioners, colleges of Pharmacy, professional organizations, and the 
Board of Pharmaceutical Specialties.  Specifically, pharmacists may wish to 
reevaluate the importance of specialty certification, while colleges of Pharmacy may 
wish to address curricula and their support of post-doctoral training programs.  Also, 
professional Pharmacy organizations may wish to enhance membership services, 
programming, etc. that relate to and support the process of specialty certification via 
board certification in Pharmacy practice.   
 
Recommendations for Future Research 
 This study revealed a great deal of information regarding the differences 
between board certified and non-board certified pharmacists.  There are several 
research projects that could be pursued based on the findings and conclusions of this 
study.  These could include the data collected from this research, use of the ACI- P 
survey instrument, or be completely new directions for study.  Some 
recommendations for future research are: 
• A cross sectional review of a comparison between BPS survey type questions 
regarding demographic nuances between former surveys completed, 
particularly the one BPS 2004 of only board certified pharmacists which was 
not anonymous , and the findings from the 2007 ACI-P survey for board 
certified and non-board certified pharmacists, which was anonymous.   
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• An evaluation of the ACI-P applied to various student class levels, 
particularly the last two years and during residencies, to focus on changing 
motivational factors during these years for a given set of students.  Tracking 
changes perceived in this population could establish a baseline for change 
implementation effect. 
• A broader test of ACI-P with full cooperation of all Pharmacy organizations 
and the schools of Pharmacy to corroborate the findings from the ACI-P 2007 
survey would be of great interest.   
• A five year annual ACI-P survey process to determine if changes in support 
of the board certification process are affecting motivation. This should be 
paralleled with a tracking of number of pharmacists seeking and attaining 
board certification in Pharmacy practice. 
• Evaluation of the impact of extended board certification categories on 
acceptance and propagation of board certification for pharmacists. 
• Evaluation of the impact of a continuing education approach on 
recertification retention rate. 
• Evaluation of ACI-P 2007 compared to subsequent years to determine 
specific profiles of pharmacists to establish a demographic profile of the 
highly motivated pharmacist. 
• Evaluation of regional, state, city, rural and urban influences on perceptions 
of board certification and motivation may be an important research topic.   
Evaluation should determine if influences are based on geographic or 
economic area or on schools and colleges of Pharmacy.  
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• The ACI-P Survey Instrument and methodology could be used for other 
health care or other disciplines, where a specialty certification is attainable 
but not necessary, to determine force of motivation.  Licensure requirements 
may make this a more complex evaluation but it could be done.  Validation is 
needed in other disciplines. 
• Additional data analysis and focus on sub-groups could provide valuable 
insight and pave the way for the future of board certification in Pharmacy 
practice and for the way Pharmacy is practiced in the future. 
 There are many other things to consider and study with the information 
gleaned from the 2007 ACI-P survey.   This is an exciting frontier for Pharmacy 
research that has little precedent.  A renewed focus and interest on specialty 
certification in Pharmacy practice could help propel the Pharmacy profession into the 
next century at the forefront of healthcare.   
 The Advanced Certification Index for Pharmacists is a valuable tool and its 
creation and validation will benefit the profession of Pharmacy.  Tracking specific 
areas of pharmacist’s perceptions can provide the profession with insights into 
particular strengths or needs.  Acting and addressing these needs and using strengths 
as a basis could lead to a material increase in the numbers of board certified 
pharmacists.  Likewise, not acting on the needs identified by the differences in 
perceptions, as indicated by the motivational factors and calculated motivational level 
as indicated by the ACI-P, may result in specialty certification in Pharmacy practice 
continuing to be an exception that is pursued and maintained by only a very small 
segment of practicing pharmacists.   
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Advanced Certification Index for Pharmacists (ACI-P) 
Manual Version Adapted from Internet Based Survey 
© Copyright Mark A. Tankersley, All Rights Reserved. 
 
 
Directions and Consent 
 
 
This survey seeks your opinions on the factors that may influence a pharmacist’s 
decision to seek board certification in a Pharmacy specialty. The survey should take 
no more than 15 minutes.  
 
Your input is important whether you have no intention of pursuing board certification 
in Pharmacy practice, intend to pursue in the future, have already completed the 
certification or were previously board certified.   
 
This survey is based on two components of each factor that may be related to pursuit 
of specialty certification in Pharmacy practice.  These components are:  1) the 
probability of occurrence as you perceive it, and 2) the value of that particular factor.  
 
Definitions: 
For the probability of occurrence (the first part of each question) the scale is a 
measure of perceived probability with the lower end “Will not occur” being the 
lowest probability of occurrence and “Will definitely occur” being the highest.  
 
For the value assessment, the lower end value of “No value” means the lowest value 
to you as a pharmacist and “Highly valuable” means the highest value to you. Please 
check the corresponding bubble for each selection.  
 
All questions are related to pursuit and achievement of board certification in 
Pharmacy by the Board of Pharmaceutical Specialties.   
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Additional Information: 
There are 16 demographic questions at the end of the survey that will be used in 
comparing this information with what has been collected by the Board of 
Pharmaceutical Specialties in previous surveys.  
 
This study has been approved by the University of Tennessee Institutional Review 
Board.  There is no consequence for refusing to take the survey or any direct benefit 
to you other than professional value to Pharmacy in general.  Your identity will not be 
disclosed and no relational information regarding your demographics information will 
be attempted.  The scope of this study is to characterize aggregate trends and not 
those of an individual.  Summary data only will be made available to Pharmacy 
organizations.  The results of this survey may be presented at a professional meeting, 
become published or become part of a Ph.D. dissertation.   
 
Consent for Participation: 
This survey is voluntary. By proceeding with this survey I consent to participate. 
 
 
Probabilities of Occurrence and Values 
 
 
1. Self image 
 A.  My self image will be improved by becoming board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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1. Self image (continued) 
 B. I value my self image.  
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
2. Employable 
 A. I would become more employable if I were board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B.  I value becoming more employable. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
3. Higher salary 
 A. I will receive a higher annual salary if I am board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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3. Higher salary (continued) 
 B. I value a higher annual salary. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
4. Professional opportunities 
 A. My professional opportunities will improve with board certification. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value professional opportunities. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
5. Peer respect 
 A. I will have increased peer respect by becoming board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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5.  Peer respect (continued) 
 B. I value peer respect. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
6. Career advancement 
 A. My career will be positively advanced by becoming board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value career advancement. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
7. Academic opportunities 
 A. My academic opportunities will improve if I am board certified. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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7.  Academic opportunities (continued) 
 B. I value academic opportunities. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
8. Downsizing protection 
 A. In a workplace that is downsizing, board certification will protect my  
 job. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value a protective effect from downsizing. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
9. Initial costs 
 A. My initial certification costs will be paid by my employer. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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9.  Initial costs (continued) 
 B. I value my initial certification costs being paid by my employer. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
10. Credibility 
 A. Board certification credentials will add credibility to my opinions. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value credentials to improve my credibility. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
11. Professional respect (Colleagues) 
 A. Other practitioners within my profession will respect my board   
 certification status. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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11.  Professional respect (Colleagues), (continued) 
 B. I value professional respect from my colleagues 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
12. Annual salary increases 
 A. If I am board certified I will receive higher annual salary increases.  
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value higher annual salary increases. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
13. Hiring influence 
 A. I would hire a board certified practitioner over another non-board   
 certified practitioner with otherwise equal qualifications. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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13.  Hiring influence (continued) 
 B. I value board certification enough to positively influence a hiring   
 decision between candidates with otherwise equal qualifications. 
 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
14. Financial incentive to SEEK board certification 
 A. Increased financial incentive from my employer would cause me to  
 SEEK board certification status. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value a financial incentive from my employer based on SEEKING  
 board certification. 
 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
15. Financial incentive to MAINTAIN board certification 
 A. Increased financial incentive from my employer would cause me to  
 MAINTAIN board certification.  
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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15. Financial incentive to MAINTAIN board certification (continued) 
 B. I value a financial incentive from my employer to MAINTAIN board  
 certification status. 
 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
16. Non-professional co-workers’ respect 
 A. Non-professional co-workers will respect board certification status. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value non-professional co-workers respect of board certification   
 status. 
 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
17. Practice skills confidence 
 A. I will have increased confidence in my practice skills as a result of   
 being board certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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17. Practice skills confidence (continued) 
 B. I value increased confidence in my practice skills. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
18. Personal accomplishment 
 A. I will feel a sense of personal accomplishment by becoming board   
 certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value personal accomplishment demonstrated by a board certification  
 credential. 
 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
19. Increased responsibility 
 A. I will have increased responsibility in my job role after    
 becoming board certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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19. Increased responsibility (continued) 
 B. I value increased responsibility in my job role. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
20. One time bonus  
 A. I will receive a one time pay bonus upon completion of board   
 certification. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value a one time pay bonus for completion of board certification. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
21. Paid certification costs 
 A. My recertification costs will be paid by my employer. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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21. Paid certification costs (continued) 
 B. I value that my employer would pay my recertification costs. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
22. Promotion potential 
 A. I will be more likely to be promoted by my employer by    
 employer if I am board certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value promotions based on board certification. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
23. Public notification 
 A. There would be a public notification of my achievement and s  
 status if I become board certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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23. Public notification (continued) 
 B. I value a public notification of my achievement and status. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
24. Improved professional network 
 A. I would have an improved professional network by becoming   
 board certified. 
 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
 
 B. I value an improved professional network. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
25. Job requirement 
 A. Board certification will become necessary for my job. 
Will definitely 
not occur 
 
? 
Unlikely to 
occur 
 
? 
Unsure 
 
 
? 
Likely to  
occur 
 
? 
Will definitely 
occur 
 
? 
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25. Job requirement (continued) 
 B. I value that my job will require board certification. 
No value 
 
 
? 
Low value 
 
 
 ? 
Mid range of 
value 
 
? 
Somewhat 
valuable 
 
? 
Highly 
valuable 
 
? 
 
 
 
Expectancy 
 
This section is based on your opinion of the likelihood of completion of board 
certification upon expenditure of the effort.  If you have no intention of pursuing 
board certification in a Pharmacy practice specialty please answer question 26.a.  
Please answer N/A as needed. 
 
26.  Expectancy 
A. I am NOT currently board certified but I feel that if I expended the effort I 
would successfully complete the board certification process. 
 
Will 
definitely 
not occur 
 
? 
Unlikely to 
occur 
 
 
? 
Unsure 
 
 
 
? 
Likely to  
occur 
 
 
? 
Will 
definitely 
occur 
 
? 
N/A 
 
 
 
? 
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26.  Expectancy (continued) 
 
B. I AM currently board certified and PRIOR TO BEGINNING preparation for 
specialty certification I felt that if I expended the effort I would successfully 
complete the requirements for board certification. 
  
Will 
definitely 
not occur 
 
? 
Unlikely to 
occur 
 
 
? 
Unsure 
 
 
 
? 
Likely to  
occur 
 
 
? 
Will 
definitely 
occur 
 
? 
N/A 
 
 
 
? 
 
 
C. I WAS formerly board certified and PRIOR TO BEGINNING preparation 
for specialty certification I felt that if I expended  the effort I would successfully 
complete the requirements for board certification. 
 
Will 
definitely 
not occur 
 
? 
Unlikely to 
occur 
 
 
? 
Unsure 
 
 
 
? 
Likely to  
occur 
 
 
? 
Will 
definitely 
occur 
 
? 
N/A 
 
 
 
? 
 
 
 
Demographics 
 
The following are demographic questions modified from previous Board of 
Pharmaceutical Specialties surveys. They are an important link from earlier studies 
findings and those from this study. 
Responses are not required for this section but are important to this research. 
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27. Please list your current memberships in professional Pharmacy organizations:  
 (Check all that apply, note these are in random order [in electronic version]) 
? AACP 
? ASHP 
? ACCP 
? APhA 
? None 
? Other (please specify): 
28. Age? 
29. Gender? 
 ? Male 
 ? Female 
30. What is your current board certification status? (List all that apply) 
 ? None, Never Certified 
 ? Board Certified Nuclear Pharmacist (BCNP) 
 ? Board Certified Nutrition Support Pharmacist (BCNSP) 
 ? Board Certified Oncology Pharmacist (BCOP) 
 ? Board Certified Psychiatric Pharmacist (BCPP) 
 ? Board Certified Pharmacotherapy Specialist (BCPS) 
 ? Formerly Certified (BCNP) 
 ? Formerly Certified (BCNSP) 
 ? Formerly Certified (BCOP) 
 ? Formerly Certified (BCPP) 
 ? Formerly Certified (BCPS) 
 
31. What is the CITY of your PRIMARY practice setting? 
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32. What is the STATE, TERRITORY or LOCATION (e.g. international work 
 location) of your PRIMARY practice setting? 
 (If not found in drop down menu please enter in box below that line: 
? AK 
? AL 
? AR 
? AZ 
? CA 
? CO 
? CT 
? DC 
? DE 
? FL 
? GA 
? HI 
? IA 
? ID 
? IL 
? IN 
? KS 
? KY 
? LA 
? MA 
? MD 
? ME 
? MI 
? MN 
? MO 
? MS 
? MT 
? NC 
? ND 
? NE 
? NH 
? NJ 
? NM 
? NV 
? NY 
? OH 
? OK 
? OR 
? PA 
? RI 
? SC 
? SD 
? TN 
? TX 
? UT 
? VA 
? VT 
? WA 
? WI 
? WV 
? WY 
? AS 
? GU 
? MP 
? PR 
? VI 
? FM 
? MH 
? PW 
? AA 
? AE 
? AP 
168 
 
33. Which of the following most closely classifies your position at your primary 
 practice site?  Multiple answers are allowed but please limit to two. 
? Staff Pharmacist 
? Clinical Staff Pharmacist 
? Clinical Manager 
? Pharmacy Manager 
? Pharmacy Director 
? Regional Manager 
? Corporate Position 
? Owner/Partner in Pharmacy Business 
? Educator 
? Researcher 
 
34. Select the ONE area from those listed below, in which the MAJORITY of  your 
practice takes place. 
? Academic Institution 
? Ambulatory Care Clinic 
? Cancer Center 
? Community Pharmacy, Chain 
? Community Pharmacy, Independent 
? Correctional Facility 
? Drug Information Center 
? Government/Military Hospital/Institution 
? Hospital, Community for Profit 
? Hospital, Community Not-for-Profit 
? Hospital, University 
? Hospital, University-Affiliated 
? Home Health Care 
? Intermediate Care Facility                            
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34. Select the ONE area from those listed below, in which the MAJORITY of  your 
practice takes place (continued). 
? Long Term Care 
? Managed Health Care, HMO, PPO or other plan 
? Managed Health Care, Pharmacy Benefits Manager 
? Nuclear Pharmacy, Centralized, Independent 
? Nuclear Pharmacy, Centralized, Chain 
? Nuclear Pharmacy, Hospital/Academic 
? Pharmaceutical Industry 
? Psychiatric Hospital/Facility 
? Specialty Pharmacy 
 
34. What is the average number of hours you typically work each week in the  practice 
of Pharmacy? 
? Less than 20 
? 20-30 
? 31-40 
? 41-50 
? 51-60 
 
35. What was your ENTRY LEVEL Pharmacy-related degree? 
 ? Bachelor's Degree 
 ? Pharm.D. 
 ? Other (please specify): 
 
 
 
170 
 
36. What is the HIGHEST Pharmacy-related degree you have earned? 
 ? Bachelor's Degree 
 ? Master's Degree 
 ? Pharm.D. 
 ? PhD 
  ? Other (please specify): 
 
37. If you earned a Pharm.D. degree, please indicate the TYPE of Pharm.D. 
 program. 
 ? 6 year, entry-level 
 ? 6 year, track-in 
 ? 1 year, post BS (Pharmacy) 
 ? 2 year, post BS (Pharmacy) 
 ? 3 year, post BS (Pharmacy) 
 ? 4 year, post BS (Pharmacy) 
 ? External/Non-Traditional 
      ? Other (please specify): 
 
38. Have you completed a residency training program? 
 ? No 
 ? Yes, post BS 
 ? Yes, post Pharm.D. 
 ? Yes, as part of Pharm.D. program 
 ? Yes, as part of MS program 
 ? Other (please specify): 
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39. In total, how many years have you worked full- and/or part-time as a licensed  
 pharmacist? 
 ? Less than 3 years 
 ? 3-5 years 
 ? 6-8 years 
 ? 9-11 years 
 ? 12-14 years 
 ? 15-17 years 
 ? 18-20 years 
 ? More than 20 years 
 
40. In total, how many years have you worked full- and/or part-time in your current area 
of specialty or practice focus? 
 ? Less than 3 years 
 ? 3-5 years 
 ? 6-8 years 
 ? 9-11 years 
 ? 12-14 years 
 ? 15-17 years 
 ? 18-20 years 
 ? More than 20 years 
 
41. Indicate your PRIMARY reason for seeking board certification. 
 ? I do not intend to pursue board certification in Pharmacy practice 
 ? Increase in salary or one time bonus (potential or actual) 
 ? Career advancement 
 ? Job requirement 
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41. Indicate your PRIMARY reason for seeking board certification (continued). 
 ? Job security  
 ? Increase in professional status 
 ? Peer recognition 
 ? Other (please specify): 
 
42. Indicate a SECONDARY reason for seeking board certification. 
 ? I do not intend to pursue board certification in Pharmacy practice 
 ? Increase in salary or one time bonus (potential or actual) 
 ? Career advancement 
 ? Job requirement 
 ? Job security 
 ? Increase in professional status 
 ? Peer recognition 
 ? Other (please specify): 
 
 
Additional Comments 
 
Additional comments related to board certification in Pharmacy practice: 
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Letters to Pharmacy Organizations Seeking Assistance and Cooperation and 
Communications of Agreement to Participate 
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Appendix C
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Permission to Reprint Figure 1-1 from the Pharmaceutical Journal 
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Appendix D 
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University of Tennessee IRB Approval (Exemption)  
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VITA 
 
 Mark Tankersley was born in Jesup, Georgia in 1957.  He grew up in the Atlantic 
coastal community of Brunswick, Georgia and the Golden Isles.  Mark has practiced 
Pharmacy since graduating from the University of Georgia in 1980.  He has worked 
directly with patients practicing in the realms of infectious disease, clinical nutrition, 
psychiatric Pharmacy, drug information and in general clinical practice in community, 
hospital, healthcare facility, nuclear Pharmacy and specialty Pharmacy settings. Mark 
also has held a variety of positions in local, regional and national managerial roles as well 
as that of a consultant providing support and assistance to healthcare organizations. He is 
an Authorized User of nuclear pharmaceuticals. 
 During his years in Pharmacy operations and clinical practice, Mark has 
participated in teaching clinical and administrative Pharmacy practice as and adjunct 
clinical instructor or faculty member for the University of Georgia, the University of 
South Carolina and The University of Tennessee Health Sciences Center. 
 While completing his graduate studies, Mark has kept current with the practice of 
Pharmacy by working continuously in patient care support roles and is currently Director 
of Medical Informatics and Outcomes at Accredo Health Group in Memphis, Tennessee.   
His interests in Pharmacy include infectious disease, clinical nutrition, applications of 
immune globulin for primary immune and neurological disorders, pulmonary arterial 
hypertension, biotechnology, health outcomes, medical informatics and clinical 
documentation systems.   
